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ABSTRACT 
 
 Mother nature creates structurally diverse interesting secondary metabolites often 
with unexpected biological activity, but in scarce quantities. Target-oriented total 
synthesis provides access to such natural products in sufficient amounts for further 
exploration of bioactivity. In target-oriented total synthesis, there is a never ending 
demand for the development of new reaction methodologies in order to address 
challenges in the synthesis and also to improve current synthetic protocols. Taking this 
idea to heart, we have worked on novel asymmetric method development and applied 
some of the methodologies that we developed to total synthesis. This thesis is composed 
of five chapters. Chapter 1 provides a general introduction to the research work discussed 
in Chapter 2, 3 and 4. Also, the introduction at the beginning of each chapter discusses 
the relevant background of the research so as to provide sufficient understanding about 
the significance of the work and the results. Moreover, some of the research in chapters 2 
and 3 was published in Org. Lett. in 2014 and rest of the work is from the manuscript 
which is currently in preparation. Also, the work disclosed in chapter 4 is published in 
Org. Lett. in full in 2015. 
Chapter 2 describes the development of a novel method for the synthesis of 
differentially protected chiral anti 1,2-diols via organomagnesium or organolithium 
addition to α-oxyaldehydes synthesized via organocatalytic oxidative incorporation of 
TEMPO. Excellent diastereoselectivity was observed in these reactions, regardless of the 
hybridization or presence or absence of branching of the incoming carbon nucleophile. 
Further attempts to access masked syn 1,2-diols using the same method via promoting 
 xi 
chelation control was unsuccessful. But, degradation of initial diastereoselectivity was 
often observed. Therefore, oxidation-reduction sequence was used to deliver syn 1,2-
diols, despite of the low diastereoselectivity.  
Chapter 3 describes the application of the methodology discussed in chapter 2, to a 
short synthesis of unnamed oxylipins isolated from Dracontium loretense. This chapter 
discuss our two successful approaches in synthesizing oxylipins. Our first generation 
synthesis describes a stereoflexible synthesis of all possible diastereomers, which led to 
the absolute stereochemical determination of natural oxylipins isolated from the 
Dracontium loretense. Moreover, a second generation synthesis provides the shortest 
route ever to immunostimulatory oxylipin with highest ever overall yield (33%). 
Chapter 4 discusses the first ever α,β,-trifunctionalization of enals using 
organocatalysis. Subjecting an enal to catalytic enantioselective aldehyde α-oxygenation 
condition led to discovery of the first ever α,β,-trioxygenation. Moderate yields and 
enantioselectivity for trioxygenation of enals were observed when using tryptophan based 
chiral imidazolidinone catalyst in fluorinated aromatic solvents.  
Chapter 5 is the conclusion of the thesis. Furthermore, it discusses future directions of 
the work is described in Chapter 4.
 1 
CHAPTER 1 
 INTRODUCTION 
Chiral catalysis has become a powerful and efficient way of introducing chirality 
in natural products.  Although, transition metal catalyzed asymmetric transformations 
have had a greater impact in synthetic organic chemistry, asymmetric transformations of 
aldehydes and enals using chiral amines as the catalysts has become popular in last 
decade and has become a hot field of research.
1
  -Functionalizations2 of aldehydes and 
-functionalizations3 of enals are the most heavily studied organocatalytic 
transformations. In addition to that, some organocatalytic remote transformations of 
carbonyl compounds have been reported.
 4
  
Organocatalytic chiral oxygenations of aldehydes and enals are important, 
because of their potential broad applications in total synthesis of natural products. The 
most common variant of this class is chiral -oxygenation of aldehydes. Moreover, these 
-oxygenation reactions proceed via enamine catalysis. Nucleophilic enamine species 
generated by the reaction between aldehyde and the chiral secondary amine traps any 
electrophilic oxygen species at the -position. Earlier examples of these chiral -
oxygenations, employed L-proline 2 as the catalyst and nitrosobenzene as the 
electrophilic oxygen source (Scheme 1).
5
 Unfortunately, nitrobenzene incorporation led 
to unstable -oxyaldehydes making these methods synthetically less useful.  Also, the 
method to -oxygenate aldehyde using radical oxygen was not synthetically appealing 
because of the poor enantioselectivity.
6 
 
 
 2 
 
 
 
 
 
Scheme 1. Proline catalyzed -oxygenation of aldehydes 
 
Further explorations of methods to improve chiral -oxygenations led to the 
discovery of oxidative incorporation of TEMPO using chiral imidazolidinones 5 as the 
catalyst (Scheme 2).
7
 Moreover, stability and high enantioselectivity of these -
oxyaldehydes is more appealing to total synthesis.  
 
 
 
 
 
Scheme 2. -Oxygenation of aldehydes catalyzed by chiral  imidazolidinones 
 
Conjugate addition of oxygen nucleophiles such as substituted hydroxylamine,
8
 
alcohols
9
 or hydrogen peroxides
10
 to iminium species formed between an enal and a 
chiral amine catalyst lead to -oxygenation. Although, there are ample examples for -
oxygenation, the reversible nature of the addition of the oxygen nucleophiles makes these 
methods less synthetically useful.
11
 Also, there is an example for nonenantioselective 
organocatalytic -oxygenation via oxidative incorporation of TEMPO.12 
 3 
Asymmetric organocascade reactions enable the setup of multiple stereocenters in 
one-pot.
13
 Difunctionalization organocascade reactions comprise ,- and ,-
difunctionalizations (Scheme 3). Conjugate addition of a nucleophile to an ,-
unsaturated iminium ion would trap a nucleophile at -position and the resultant enamine 
which is nucleophilic at the -position would trap an electrophile.  Although, there are 
some examples for forming a three-membered ring when  and  carbons of enal can 
form bonds to the same atom of the incoming group,
14
 the most common variants have 
two different reaction partners at  and  carbons . However, there is no such a literature 
precedent for ,-dioxygenation cascade reactions, although ,-difunctionalizations 
involving either -15 or -monooxygenation16,9c is precedented. 
 
 
Scheme 3. Organocatalytic difunctionalization cascades 
 
,-difunctionalizations using organocatalysis are known.17 But, there is no 
precedent for a cascade ,,-trifunctionalization (or trioxygenation) of enals under any 
conditions. But, Fu et. al., Smith et. al. and Romo et. al. have reported some cascade 
ipso,,-trifunctionalizations of activated carboxylic acid derivatives using 
organocatalysis (Scheme 4).
18
  
 4 
 
 
Scheme 4. ipso,α,β-trifunctionalization cascade of activated carboxylic derivatives 
 
Chiral 1,2-diols are among commonly found functional groups in natural products. 
The Sharpless asymmetric dihydroxylation
 
 is the default choice to access such chiral syn-
1,2-diols in high enantioselectivity from trans alkenes. One common disadvantage of the 
Sharpless asymmetric dihydroxylation is the poor enantiomeric ratio when cis alkenes are 
converted into corresponding anti-1,2-diols.
19
 As an alternative to this fundamental 
limitation of the Sharpless asymmetric dihydroxylation in delivering chiral anti-1,2-diols, 
carbon–carbon bond formation reactions are used. The middle carbon–carbon bond 
between the two carbenol carbons of anti-1,2-diols could be formed by nucleophilic 
addition to an aldehyde constructing both stereocenters simultaneously. Enolates or enols 
derived from -oxycarbonyl compounds20-22 and functionalized allyl reagents23,24 are 
suitable nucleophiles capable of such a transformation. Also, nucleophilic addition to a 
chiral -oxyaldehyde with substrate-,25,26  reagent-,27 or catalyst-based28 stereocontrol can 
deliver anti-1,2-diols too. Although, prior setting of the -chiral center of the aldehyde 
required, the large substrate scope of this approach makes more appealing. Moreover, a 
method employing nucleophilic addition to an epoxyalcohol
29
 to deliver anti-1,2-diols is 
more appealing, because these epoxy alcohols can be prepared with desired 
stereochemistry by kinetic resolution of a racemic allylic alcohol through the Sharpless 
asymmetric epoxidation.
30
 Furthermore, anti-1,2-diols can be accessed by alkene 
epoxidation followed by epoxide opening,
31
 allylic substitution reactions
32 
and 
desymmetrization reactions.
33
 
 5 
Nucleophilic addition to -oxyaldehydes25–28 is more appealing for diol synthesis 
for two reasons. One is the broad range of nucleophiles available for such a 
transformation. The other reason is the substrate-controlled stereoinduction that can be 
achieved, based on the masking group on the chiral -hydroxyl group. For an example a 
-TBS ether may promote polar Felkin-Anh control, whereas -benzyl ether could 
facilitate chelation control.
25,26a 
 Previously, chiral -oxyaldehydes required multiple 
steps to prepare because of the unavailability of direct -oxygenations. But, now direct 
aldehyde -oxygenation is available via organocatalysis and such -oxyaldehydes could 
be accessed in one step from the starting aldehydes.
7
 
 
Scheme 5. Natural oxylipins (13, 14 and 15) and Nigricanoside A (16) 
 
Glactolipid Nigricanoside A 16 (Scheme 5) is a scarce natural product isolated from 
the green algae Avrainvillea nigricans in 2001.
33 
The isolation chemists reported an 
exceptional cytotoxicity via microtubule-stabilizing activity, which drew our attention as 
a synthetic target (But, in 2015, Nigricanoside A was found to be lacking reported 
bioactivity).
35
 Unnamed oxylipins 13 and 14 (Scheme 5) were isolated from the Peruvian 
 6 
plant Dracontium loretense in trace quantities.
36
 Moreover, oxylipin 13 has shown 
immunostimulatory properties while oxylipin 14 is bio-inactive. However, the isolation 
chemists were only able to assign relative stereochemistry of C-9 and C-10 stereocenters 
of oxylipins 13 and 14, while the stereochemistry of C-6 was undetermined. These fatty 
acid derivatives share the same stereochemically-unassigned trioxygenated motif (3-ene-
1,2,5 triol moiety) found in the fatty acid domains of Nigricanoside A 16, qualifying 
them to be  an ideal model system for synthetic method development.  
There are five total syntheses are reported for these oxylipins other than ours.
37
 
Sharma et. al.
37a
 and Narsaiah et. al.
37b
 each reported a synthesis single isomer oxylipin. 
Neither group interested in comparing their synthetic compounds with the spectroscopic 
data of natural oxylipins, which prevented them from making a stereochemical 
assignment. Barua et. al.
37c
 reported a synthetic route to both diastereomers of natural 
oxylipins. This synthesis also didn’t lead to a stereochemical assignment because, the 
reported NMR data of their synthetic oxylipins was in CDCl3, which was different from 
what the isolation team used (CD3OD).
 
Moreover, in the synthesis which is reported by 
Reddy et. al.
37d
 compared their NMR spectral data with a synthetic oxylipin instead of 
that of isolation chemists’.37d This ambiguity of the absolute stereochemistry urged us to 
devise a stereochemically flexible route to all four diastereomers of oxylipins in order to 
make an unambiguous absolute stereochemical determination.  Moreover, pinellic acid 15 
which has been a target for several syntheses,
38
 is closely related in structure to these 
oxylipins. Only the synthesis
38a
 by Ōmura was able to furnish all possible diastereomers 
of pinnelic acid, while Kuwahara synthesis
38b
 is the shortest ever synthetic route with 7 
linear steps. 
 7 
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Tetrahedron Lett. 2007, 48, 5701. (e) Reyes, E.; Talavera, G.; Vicario, J. L.; 
Badía, D.; Carrillo, L. Angew. Chem., Int. Ed. 2009, 48, 5701. (f) Lin, S.; 
Zhao, G.-L.; Deiana, L.; Sun, J.; Zhang, Q.; Leijonmarck, H.; Córdova, A. 
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CHAPTER 2 
 CHIRAL anti-1,2-DIOLS FROM -OXYALDEHYDES 
Published in part in Org. Lett.
* 
Manuscript in preparation 
Introduction 
Chiral 1,2-diols are among the most common functional groups found in natural products. 
Although, the Sharpless asymmetric dihydroxylation provides a powerful mean to access 
syn-1,2-diols from trans alkenes, poor enantioselectivity was often observed when cis 
alkenes were converted to anti-1,2-diols.
1
 To circumvent this fundamental limitation of 
the Sharpless dihydroxylation in anti-1,2-diols synthesis, C-C bond formation reactions 
are employed as outlined in Figure 1. Anti-1,2-diols 1 may be formed by nucleophilic 
addition of enolates and enols derived from α-oxycarbonyl compounds2-4 and 
functionalized ally reagents
5-6
 to aldehydes 2 (method a), constructing the central C-C 
bond while setting the both stereocenters at the same time. Nucleophilic addition to chiral 
α-oxyaldehydes 3 with substrate-,7-8 reagent-9 or catalyst-control10 gives anti-1,2-diols 
forging a C-C bond next to the diol moiety (method b). Although prior setting up of one 
chiral center is necessary, a larger substrate scope makes this approach appealing. Anti 
diol synthesis can also be envisioned via nucleophilic addition to an epoxyalcohol 4 
(method c).
11
 The synthesis of epoxyalcohols 4 via kinetic resolution of racemic allylic 
alcohols followed by a Sharpless asymmetric epoxydation makes this method attractive.
12 
Moreover anti-1,2-diols can be accessed by alkene epoxidation followed by epoxide 
opening,
13
 allylic substitution reactions
 14
 and desymmetrization reactions.
15
 
*
Org. Lett. 2014, 16, 32 
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Figure 1. Strategies towards making anti 1,2-diols 
 
Unstable -oxyaldehyde products in organocatalytic nitrosobenzene 
incorporation
16
 and poor stereoselectivity of singlet oxygen incorporation
17
 led us to 
consider oxidative incorporation of TEMPO
18
 in preparation of an -oxyaldehyde for 
diol syntheses. Moreover, a 2,2,6,6-tetramethylpiperidinyl masking group at the -
oxygen can promote both polar Felkin-Ahn (due to steric congestion) and chelation 
control (through basic nitrogen or oxygen) pathway for nucleophilic addition depending 
on the choice of reaction conditions. 
 
 
Result and discussion 
In 2011, MacMillan showed that these -oxyaldehydes can undergo a variety of 
transformations including Grignard additions, aldol reactions, Wittig reactions etc. 
without degrading the enantiomeric ratio.
18d
  Furthermore, he reported a Grignard 
addition to these -oxyaldehydes to give masked syn-1,2-diol 6, whereas the related aldol 
 15 
addition gave a  masked anti-1,2-diol 7 (Scheme 1.). Also, Maruoka reported a Grignard 
addition to these -oxyaldehydes to give a masked anti-1,2-diol.18b We were surprised by 
the stereochemical oddity of the outcomes of similar nucleophilic addition to -
oxyaldehydes. Therefore, we independently investigated the related Grignard addition to 
-oxyaldehydes. Diol 12 was prepared by a Grignard addition to -oxyaldehyde 8 
followed by reductive cleavage (Zn, AcOH)
19
 of the N-O bond of the -OTMP moiety  
(Scheme 2). NMR spectroscopic
 
and the optical rotation comparison
 
with known syn
20
 
and anti isomers
21
 revealed that masked diol 11 to have anti stereochemical relationship. 
We confirmed the stereochemical outcome of the Grignard addition to the -
oxyaldehydes to be anti.
22 
Therefore, polar Felkin-Anh control predominates in Grignard 
addition to such -oxyaldehyde 8. 
 
 
 
 
 
 
 
 
 
 
Scheme 1. Some published reactions of α-oxyaldehydes 
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Scheme 2. Determination of stereochemical outcome of the Grignard addition to -oxyaldehydes  
 
Our attempts to improve the selectivity and yield of the Grignard addition are 
summarized in Table 1. Modest yield and selectivity were observed when the addition of 
n-butylmagnesium chloride to aldehyde 10 was conducted in ether at 0 C. The primary 
alcohol formed by the reduction of aldehyde 10 was a significant side product under these 
conditions. Both yield and selectivity were improved further when THF was used as the 
solvent for the n-butylmagnesium chloride addition. Aldehyde reduction to primary 
alcohol was observed to be suppressed in THF. But, poor yield and diastereoselectivity 
were observed when using more polar dioxanes as solvent. However, superior yields and 
selectivity were observed when lowering the temperature to -78 C in THF. Despite the 
high yield, modest selectivity was observed when changing the nucleophile to n-
butyllithium in THF. But the selectivity could be recovered when hexanes is used as a 
solvent for n-butyllithium addition at -78 C. 
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Table 1. Tuning the Diastereoselectivity
a
 of Grignard addition to α-oxyaldehydes 
 
 
 
 
 
 
 
 
 
 
 
 
a0.8 1.0 mmol scale. bDetermined by 1H-NMR analysis of the crude mixture. cIsolated yield of a mixture of 
diastereomers. dEstimated by 1H-NMR analysis of the crude mixture. Major byproduct was primary alcohol derived 
from aldehyde reduction. 
 
 
Both functional group tolerance of the α-oxygenation and the Grignard addition to 
aldehydes were well investigated previously.
18d
 Therefore, we were more interested in a 
study of the variation of the diastereoselectivity of the Grignard addition to α-
oxyaldehydes with different classes of Grignard reagents considering the branched, 
unbranched, and hybridization of the Grignard reagent. Although, good selectivity was 
observed in the isopropylmagnesium bromide addition, the yield was modest due the 
significant reduction of aldehyde 10 to the corresponding primary alcohol. Reduction was 
found to be suppressed by premixing aldehyde 10 with CeCl3 but little degradation of the 
diastereoselectivity was resulted due to chelation. Excellent selectivities were observed 
for sp
2
 Hybridized Grignard reagents. However, the selectivity in ethynylmagnesium 
bromide addition was moderate, possibly due to low steric interactions.  
Surprisingly, allylmagnesium bromide addition to aldehyde 10 gave syn-1,2-diol 
as the major product with little selectivity for either diastereomer. The slight preference 
M solvent Temp (C) dr
b 
yield
 c 
(%)
 
MgCl E2O 0 4:1 60
d 
MgCl THF 0 6:1 70
 
MgCl Dioxanes 0 3:1 50
d
 
MgCl THF -78 10:1 86 
Li THF -78 6:1 81
 
Li hexanes -78 12:1 84 
 18 
for the syn 1,2-diol with allylmagnesium bromide addition may be explained by the 
chelation control or by a different stereoinduction model such as the Zimmerman-Traxler 
model. However, benzylmagnesium bromide addition follows polar Felkin-Ahn control, 
as observed with other Grignard reagents, to give the anti-1,2-diol despite the low 
diastereoselectivity.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a1 mmol scale. bUsed n-butylmagnesium chloride. cIsolated yield of a mixture of diastereomers. dDetermined by 1H-
NMR analysis of the crude mixture. eEstimated by 1H-NMR analysis of the crude mixture. Major product was primary 
alcohol derived from aldehyde reduction.  f1.5 equiv of CeCl3 added. 
gIsolated yield of a single diastereomer. 
 
 
Scheme 3. anti-1,2-diol synthesis varying the carbon nucleophile
a
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Scheme 4. syn-1,2-Diol synthesis via oxidation and reduction 
 
 
Degradation of diastereoselectivity in 1,2-diol synthesis upon premixing with 
CeCl3 with isopropylmagnesium bromide (Scheme 3, 13) to suppress the reduction of 
aldehyde gave a hope in optimizing the diol synthesis towards syn selectivity via 
chelation control.  In light of this observation, oxyphilic Lewis acids, solvents and 
temperature were screened to promote chelation control. Early transition metal salts (e.g. 
scandium and titanium salts), late transition metal salts (e.g. copper and zinc salts), main 
group complexes (e.g. boron, aluminum complexes) and lanthanide salts (e.g. cerium, 
samarium and lanthanum salts) were found to be ineffective in degrading initial 
diastereomeric ratio to favor syn-1,2-diols. Butylmagnesium chloride addition to 
aldehyde 10 in the presence of the above mentioned oxophillic salts in ethereal solvents 
always gave anti-1,2-diols as the major product.  Only lithium triflate and lithium 
chloride in diglyme at RT was found to be effective in bringing the diastereoselectivity 
down to 2.2:1 and 2.5:1 respectively with good yields (80% and 85% crude NMR yields 
of both diastereomers, respectively). Since polar Felkin-Anh control is predominating 
always in this system, hydride addition to the corresponding ketone should also occur 
 20 
from the least hindered site inverting the stereocenter of the free alcohol. Therefore, 
oxidation of the free alcohol moiety of the anti-1,2-diol to a ketone and reduction of the 
corresponding ketone is a viable route to syn-1,2-diols. As a result, an oxidation and 
reduction sequence was used as shown in Scheme 4 in syn 1,2-diol synthesis. IBX 
oxidation of alcohol 11 to ketone 20 followed by NaBH4 gave an inseparable 
diastereomeric mixture of masked 1,2-diols favoring syn stereoisomer 21  in only a 1.7:1 
diastereomeric ratio in 90% yield. 
The 
1
H NMR peak for the hydroxyl proton of both masked anti- and syn-1,2-diol 
unusually far apart (by 5 ppm). Moreover, the 
1
H NMR peak for the hydroxy proton of 
compounds 11 and 13-19 consistently appeared at ca. 2 ppm for the major diastereomer 
(masked anti-1,2-diol) and at ca. 7 ppm for the minor diastereomer (masked syn-1,2-
diol). The exact 
1
H NMR chemical shifts of the hydroxy protons of the major and minor 
diastereomers of compounds 11 and 13-19 are summarized in Table 2 below. Using the 
built in stereochemical probe that we developed we established the stereochemistry of the 
Grignard product 6 (Scheme 1) to be anti, which was previously misassigned by 
MacMillan.
18d 
Also, we confirmed the stereochemistry of the aldol product 17 (Scheme 
1) to be syn using this built in stereochemical probe. 
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Table 2. 
1
H NMR Chemical shifts of hydroxyl protons of major (anti) and   minor (syn) masked 1,2-diols 
of 11 and 13-19 
 
 
 
 
 
 
 
 
 
a 
Masked by the aromatic protons. 
b
Minor diasteremor. 
c
Major diastereomer. 
 
 
Conclusion 
We developed a promising method to access differentially protected anti-1,2-diols with 
high diastereoselectivity via Grignard additions to -oxyaldehydes. Moreover, high 
diastereomeric ratios were observed regardless of the branched/unbranched nature or 
hybridization of the Grignard reagent. Furthermore, this method can be used as an 
alternative to the Sharpless dihydroxylation, which has a fundamental limitation in 
delivering anti-1,2-diols with high enantioselectivity. Attempts to optimize the above diol 
technology to access syn-1,2 diols using chelation control, were not successful, although 
degradation of the initial diastereomeric ratio was often observed. Therefore, an 
oxidation-reduction sequence was used to access syn-1,2-diols from anti-1,2-diols 
utilizing the dominating Felkin-Ahn control. 
 
 
Compound 
Chemical shift of hydroxyl protone in CDCl3 
major diastereomer (anti) minor diastereomer (syn) 
11 2.03 7.31 
13 1.94 7.05 
14 2.50 7.53 
15 2.15 7.46 
16 2.41 c. a. 7
a
 
17 2.45 7.56 
18 2.26
 b
 7.33
c
 
19 2.05 c. a.7
a
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Experimental  
General procedures 
Unless otherwise noted, all reactions were performed with stirring under an argon 
atmosphere under anhydrous conditions. Organomagnesium and -lithium reagents were 
purchased from Aldrich. All other reagents were purchased at the most-economical 
grade. Dry tetrahydrofuran (THF), N,N-dimethylformamide (DMF), dichloromethane, 
and toluene were obtained by passing HPLC grade solvents through commercial solvent 
purification systems. All other chemicals were used as received, without purification. 
Flash column chromatography was performed using Grace Davison Davisil silica gel (60 
Å, 35 – 70 m). Unless otherwise noted, yields refer to chromatographically- and 
spectroscopically- (
1
H NMR) homogeneous samples of single diastereomers. Thin-layer 
chromatography (TLC) was performed on Grace Davison Davisil silica TLC plates using 
UV light and common stains for visualization. NMR spectra were calibrated using 
residual undeuterated solvent as an internal reference. Apparent couplings were 
determined for multiplets that could be deconvoluted visually. 
 
Aldehyde 10: To a mixture of activated   4 Å molecular sieves (500 mg, 
powdered) and imidazolidinone catalyst 9 (1.22 g, 4 mmol, 0.2 equiv.) in 
12 mL acetone was added CuCl2·2H2O (340 mg, 2 mmol, 0.1 equiv.). 
The green reaction mixture was stirred open to air for 5 minutes until the copper salt 
dissolved and the mixture turned dark orange. The reaction was cooled to 0 °C for 10 
minutes, then hexanal (8; 2.50 mL, 20 mmol, 1.0 equiv.) was added dropwise over 2 
minutes. The reaction was stirred at 0 °C for 10 minutes, then a solution of TEMPO (3.75 
 23 
g, 24 mmol, 1.2 equiv.) in 6 mL of acetone was added dropwise over 3 minutes. The 
reaction mixture was capped with a rubber septum and an air inlet line was attached via 
an 18-gauge needle. The reaction was stirred at 0 °C for 24 hours, then partitioned 
between ether (50 mL) and saturated NH4Cl (150 mL). The aqueous layer was extracted 
with ether (2 × 150 mL) and the combined organic layers were washed with brine (300 
mL). The organic layer was dried over Na2SO4, filtered, and concentrated to give an 
orange oil. Flash column chromatography (3 % EtOAc / hexanes) gave -oxyaldehyde 10 
(3.91 g, 77 % yield) as a colorless oil. A sample was derivatized [1. NaBH4, MeOH; 2. 
m-nitrobenzoyl chloride, Et3N, DMAP (cat.), CH2Cl2; 3. Zn, AcOH, THF, H2O] and 
determined by chiral HPLC [Chiraltech IC column, 2.1 × 100 mm, 3 m; 10 % iPrOH / 
hexanes, 0.2 mL / min, 25 °C; 280 nm UV detection; Rt = 8.7 (major), 10.0 (minor) 
minutes] to have 89:11 er. 10: Rf = 0.44 (5 % EtOAc / hexanes); []D
23
 = −77.0 ° (c = 
1.00, CHCl3); IR (thin film): max = 2933, 1732 cm
–1
;
 1
H NMR (600 MHz, CDCl3):  = 
9.77 (d, J = 4.4 Hz, 1H), 4.07 (dt, J = 8.9, 5.2 Hz, 1H), 1.74 (m, 1H), 1.66 (m, 1H), 1.48 – 
1.10 (m, 22H), 0.90 (t, J = 6.1 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3):  = 204.74, 
88.74, 40.26, 31.97, 30.14, 29.82, 29.48, 29.31, 24.40, 22.78, 17.29, 14.23 ppm; HRMS 
(ESI-QTOF) calcd for C15H30NO2
+
 [M + H
+
]: 256.2277, found: 256.2278. 
 
Alcohol 11: To a solution of aldehyde 10 (200 mg, 0.78 mmol, 
1.0 equiv.) in 780 L of THF at –78 °C was added nBuMgCl 
(2.0 M in ether, 590 µL, 1.5 mmol, 1.5 equiv.) dropwise over 3 
minutes. The resultant solution was stirred at –78 °C for 30 minutes, then warmed to 
ambient temperature. The reaction mixture was partitioned between saturated NH4Cl (5 
 24 
mL) and ether (20 mL). The organic phase was washed with water (2 × 20 mL) and brine 
(10 mL), dried over Na2SO4, and concentrated to give a colorless oil. Flash column 
chromatography (4 % EtOAc / hexanes) gave alcohol 11 (210 mg, 86 % yield, 10:1 
mixture of diastereomers) as a colorless oil. 11: Rf = 0.27 (5 % EtOAc / hexanes); []D
23
 
= −8.3 ° (c = 1.00, CHCl3); IR (thin film): max = 3583, 2933 cm
–1
; 
1
H NMR (600 MHz, 
CDCl3):  = 3.88 (m, 2H), 2.03 (s, 1H), 1.82 (m, 1H), 1.61 – 1.24 (m, 18H), 1.23 – 1.08 
(m, 11H), 0.91 (m, 6H) ppm; 
13
C NMR (150 MHz, CDCl3):  = 84.94, 72.45, 40.79, 
31.75, 29.09, 28.75, 23.42, 22.93, 17.37, 14.24 ppm; HRMS (ESI-QTOF) calcd for 
C19H40NO2
+
 [M + H
+
]: 314.3059, found: 314.3056. 
 
Alcohol 13: To a suspension of cerium(III) chloride in 0.2 mL of THF at –78 °C was 
added iPrMgBr (1.0 M in THF, 1.50 mL, 1.5 mmol, 1.5 equiv.). 
After 30 minutes at –78 °C, aldehyde 10 (255 mg, 1.0 mmol, 1.0 
equiv.) in 1 mL of THF was added dropwise over 5 minutes. The 
resultant solution was stirred at –78 °C for 30 minutes, then warmed to ambient 
temperature. The reaction mixture was partitioned between saturated NH4Cl (5 mL) and 
ether (20 mL). The organic phase was washed with water (2 × 20 mL) and brine (10 mL), 
dried over Na2SO4, and concentrated to give a colorless oil. Flash column 
chromatography (5 % EtOAc / hexanes) gave alcohol 13 (85 % yield, 6:1 mixture of 
diastereomers) as a colorless oil. 13: Rf = 0.42 (10 % EtOAc / hexanes); []D
23
 = −8.2 ° 
(c = 1.00, CHCl3); IR (thin film): max = 3584, 2932 cm
–1
; 
1
H NMR (600 MHz, CDCl3):  
= 3.95 (m, 1H), 3.66 (m, 1H), 1.94 (d, J = 3.92 Hz, 1H), 1.73 (m, 2H), 1.54 – 1.07 (m, 
23H), 1.02 (d, J = 6.5 Hz, 3H), 0.93 – 0.88 (m, 6H) ppm; 13C NMR (150 MHz, CDCl3):  
 25 
= 83.49, 77.20, 60.16, 40.86, 30.07, 29.32, 23.60,19.89, 19.36, 17.34, 14.23; HRMS 
(ESI-QTOF) calcd for C17H38NO2
+
 [M + H
+
]: 300.2897, found: 300.2900. 
 
Alcohols 11, 13–19 were prepared in the same manner as alcohol 11 using the 
appropriate solutions of organomagnesium bromide reagents dissolved in THF. 
 
Alcohol 14: Flashcolumn chromatography (4 % EtOAc / hexanes) gave pure alcohol 14 
(78 % yield) as a colorless oil as well as a mixture of diastereomers 
(11 % yield) as a colorless oil. 14: Rf = 0.51 (10 % EtOAc / hexanes); 
[]D
23
 = +10.0 ° (c = 1.00, CHCl3); IR (thin film): max = 3580, 3052, 
2934, 1467 cm
–1
; 
1
H NMR (600 MHz, CDCl3):  = 5.94 (m, 1H), 5.29 (d, J = 17.2 Hz, 
1H), 5.18 (d, J =10.6 Hz, 1H), 4.44 (m, 1H) 3.99 (m, 1H), 2.50 (s, 1H), 1.80 (m, 1H), 
1.64 – 1.06 (m, 23H), 0.90 (t, J = 6.9 Hz, 3H) ppm; 13C NMR (150 MHz, CDCl3):  = 
137.44, 115.88, 84.36, 73.94, 60.38, 40.77, 28.84, 28.59, 23.27, 17.33, 14.20 ppm; 
HRMS (ESI-QTOF) calcd for C17H34NO2
+
 [M + H
+
]: 284.2584, found: 284.2587. 
 
Alcohol 15: Flash column chromatography (4 % EtOAc / hexanes) gave pure alcohol 15 
(79 % yield) as a colorless oil as well as a mixture of diastereomers 
(5 % yield) as a colorless oil. 15: Rf = 0.42 (10 % EtOAc / hexanes); 
[]D
23
 = −8.2 ° (c = 1.00, CHCl3); IR (thin film): max = 3497, 2929, 
1461 cm
–1
; 
1
H NMR (600 MHz, CDCl3):  = 5.06 (m, 1H), 4.91 (m, 1H), 4.51 (m, 1H), 
3.96 (m, 1H) 2.15 (d, J = 4.0 Hz, 1H), 1.76 (s, 3H), 1.66 (m, 1H), 1.53 – 1.06 (m, 23H), 
0,89 (t, J = 6.7 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3):  = 144.68, 111.37, 83.61, 
 26 
75.13, 74.87, 40.88, 29.28, 27.93, 23.39, 20.19, 17.33, 14.20 ppm; HRMS (ESI-QTOF) 
calcd for C18H36NO2
+
 [M + H
+
]: 298.2741, found: 298.2743. 
 
Alcohol 16: Flash column chromatography (4 % EtOAc / hexanes) gave pure alcohol 16 
(73 % yield) as a colorless oil as well as a mixture of diastereomers 
(4 % yield) as a colorless oil. 16: Rf = 0.34 (10 % EtOAc / 
hexanes); []D
23
 = −7.9 ° (c = 1.00, CHCl3); IR (thin film): max = 
3484, 2930, 1464 cm
–1
; 
1
H NMR (600 MHz, CDCl3):  = 7.38 (d, J = 7.7 Hz, 2H), 7.32 
(t, J = 7.4 Hz, 2H), 7.24 (t, J = 7.4 Hz, 1H), 5.22 (m, 1H), 4.06 (m, 1H), 2.41 (d, J = 4.2 
Hz, 1H), 1.68 (m, 1H), 1.54 – 0.96 (m, 23H), 0.79 (t, J = 7.4 Hz, 3H)ppm; 13C NMR 
(150 MHz, CDCl3):  = 128.11, 127.02, 126.52, 86.47, 73.62, 40.88, 29.07, 27.45, 23.24, 
17.36, 14.09; HRMS (ESI-QTOF) calcd for C21H36NO2
+
 [M + H
+
]: 334.2741, found: 
334.2743. 
 
Alcohol 17: Flash column chromatography (4 % EtOAc / hexanes) gave pure alcohol 17 
(67 % yield) as a light yellow oil as well as a mixture of 
diastereomers (16 % yield) as a light yellow oil. 17: Rf = 0.36 (10 % 
EtOAc / hexanes); []D
23
 = −33.4 ° (c = 1.00, CHCl3); IR (thin film): 
max = 3583, 3303, 2934, 2306, 1467 cm
–1
; 
1
H NMR (600 MHz, CDCl3):  = 4.83 (s, 1H), 
4.64 (s, 1H), 4.25 (m, 1H), 2.45 (s, 1H), 1.78 (m, 1H), 1.64 – 1.05 (m, 23H), 0.92 (t, J = 
7.0 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3): 83.11, 81.69, 74.58, 66.20, 61.36, 60.80, 
40.95, 40.68, 35.01, 34.21, 30.08, 28.61, 23.15, 20.71, 17.26, 14.16 ppm; HRMS (ESI-
QTOF) calcd for C17H32NO2
+
 [M + H
+
]: 282.2428, found: 282.2429. 
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Alcohol 18: Prepared by the above method. Flash Column 
Chromatography (5% EtOAc / hexanes) gave diol 18 as an 
inseperable mixture of diastereomers (262mg, 88% yield, 1.4:1 
mixtures of diastereomers) as colorless oil. 18: Rf = 0.33 (5% EtOAc / hexanes); []D
23
 = 
–27.4 (c = 1.00, CHCl3); IR (thin film): max = 3429, 2928, 2871, 1640 cm
–1
; 
1
H NMR 
(600 MHz, CDCl3):  = 7.33 (brs, 1H), 5.98–5.93 (m, 1H), 5.16–5.01 (m, 2H), 4.02–3.85 
(m, 2H), 2.26 (m, 1H), 2.09 (m, 1H), 1.93–1.04 (m, 24H), 0.91 (t, J= 7.4 Hz, 3H) ppm ; 
13
C NMR (150 MHz, CDCl3):  = 135.2, 116.5, 82.9,74.8, 61.7, 60.2, 40.5, 37.0, 32.1, 
28.9, 23.1, 20.7, 17.3, 14.1 ppm; HRMS (ESI-QTOF) calcd for C18H36NO2
+
 [M + H
+
]: 
298.2746, found: 298.2742. 
 
Alcohol 19: Prepared by the above method. Flash Column 
Chromatography (3% EtOAc / hexanes) gave alcohol 19 (174 
mg, 50% yield) as an colorless oil and mixture of diastereomers 
(76 mg, 22% yield, 3.4:1 mixture diastereomers). 19: Rf = 0.30 (4 % EtOAc / hexanes); 
[]D
23
 = –10.8 ° (c = 1.00, CHCl3); IR (thin film): max = 3480, 3028, 2928 cm
–1
; 
1
H 
NMR (600 MHz, CDCl3):  = 7.30 (t, J = 7.6 Hz, 2H), 7.27 (m, 2H), 7.21 (tt, J= 7.3, 1.3 
Hz, 1H), 4.23 (m, 1H), 3.95 (dt, J = 6.0, 2.3 Hz, 1H), 2.83–2.73 (m, 2H), 2.05 (d, J = 5.8 
Hz, 1H), 1.90 (m, 1H),  1.64–1.28 (m, 11H), 1.20 (brs, 3H), 1.14 (brs, 6H), 1.09 (brs, 
3H), 0.93 (t, J= 7.1 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3):  = 139.6, 129.4, 128.5, 
126.3, 84.4, 73.3, 40.8, 39.1, 29.1, 28.8, 23.4, 17.4, 14.3 ppm; HRMS (ESI-QTOF) calcd 
for C22H38NO2
+
 [M + H
+
]: 348.2903, found: 348.2900. 
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Diol 12: To a solution of alcohol 11 (240 mg, 0.77 mmol, 1.0 
equiv., 12:1 mixture of diastereomers) in 5 mL of a 3:1:1 
solvent mixture (HOAc:H2O:THF) was added zinc (500mg, 7.7 
mmol, 10 equiv.). The reaction mixture was stirred at 70 °C for one hour. After cooling, 
the reaction mixture was filtered through Celite, concentrated, and azeotroped dried with 
toluene to give a white solid. Flash column chromatography (30 % EtOAc / hexanes) 
gave known diol 12
21
 (102 mg, 76 % yield, 18:1 mixture of diastereomers) as a white 
solid.  
 
Ketone 20: To a solution of alcohol 11 (266 mg, 0.85 mmol, 
1.0 equiv.) in 3 mL of THF was added a solution of IBX (309 
mg, 1.11 mmol, 1.3 equiv.) in 1 mL of DMSO. The reaction 
mixture was stirred for 1.5 hours, then diluted with 50 mL of ether and filtered. The 
organic phase was washed with water (3 × 50 mL) and brine (30 mL), dried over Na2SO4, 
and concentrated to give a colorless oil. Flash chromatography (3% EtOAc / hexanes) 
gave ketone 20 (251 mg, 95% yield) as a colorless oil. 20: Rf = 0.31 (3% EtOAc / 
hexanes); []D
23
 = –16.6 ° (c = 1.00, CHCl3); IR (thin film): max = 2930, 1713 cm
–1
; 
1
H 
NMR (600 MHz, CDCl3):  = 4.14 (dd, J = 9.5, 4.0 Hz, 1H), 2.66 (ddd, J = 18.0, 8.8, 6.3 
Hz, 1H ), 2.46 (ddd, J = 18.0, 8.5, 6.3 Hz, 1H ), 1.89 (m, 1H),  1.69 (m, 1H), 1.56 (m, 
3H), 1.43 (m, 4H), 1.38–0.94 (m, 19H), 0.92 (t, J= 7.4 Hz, 3H) ppm, 0.87 (t, J= 7.3 Hz, 
3H) ppm; 
13
C NMR (150 MHz, CDCl3):  = 212.6, 91.2, 40.5, 39.2, 31.5, 26.7, 25.2, 
22.9, 22.6, 17.3, 14.08, 14.05ppm; HRMS (ESI-QTOF) calcd for C19H38NO2
+
 [M + H
+
]: 
312.2903, found: 312.2900. 
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Alcohol 21: Ketone 20 (230 mg, 0.74 mmol, 1.0 equiv.) in 4.0 
mL Ethanol at 0 °C was added NaBH4 (42 mg, 1.11 mmol, 1.5 
equiv.). The reaction mixture was stirred for one hour, then 
diluted with ether (50 mL), washed with saturated NH4Cl (50 mL), water (50 mL) and 
brine (30 mL). The organic layer was dried over Na2SO4, filtered and concentrated to 
give a colorless orange oil. Flash chromatography (5% EtOAc/ Hexanes) gave alcohol 21 
as an inseperable mixture of diastereomers (208 mg, 90% yield, 1.7:1 mixtures of 
diastereomers ). 21: Rf = 0.27 (5% EtOAc / hexanes); []D
23
 = 44.2 ° (c = 1.00, CHCl3); 
IR (thin film): max = 3214, 2928,  cm
–1
; 
1
H NMR (600 MHz, CDCl3):  = 7.31 (brs, 1H), 
3.92–3.82 (m, 2H), 1.66–1.07 (m, 30H), 0.92 (t, J= 7.0 Hz, 3H), 0.90 (t, J= 7.0 Hz, 3H) 
ppm; 
13
C NMR (150 MHz, CDCl3):  = 83.5, 75.1, 61..7, 60.2, 40.5, 40.0, 33.7, 32.2, 
30.7, 28.7, 27.7, 27.1, 23.14, 23.07, 20.7, 17.3, 14.26, 14.19 ppm; HRMS (ESI-QTOF) 
calcd for C19H40NO2
+
 [M + H
+
]: 314.3059, found: 314.3059. 
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CHAPTER 3 
TOTAL OF SYNTHESIS OF OXYLIPINS ISOLATED FROM  
Dracontium loretence 
Published in part in Org. Lett.
* 
Manuscript in preparation 
                                                 Introduction 
Oxylipins are a class of oxygenated secondary metabolites of fatty acids. These 
have wide range of distribution and functions in aerobic organisms.
1
 Among the linear 
oxylipins isolated from the Peruvian plant Dracontium loretense, fatty acid 1 has shown 
immunostimulatory properties whereas fatty acid 2 is biologically inactive (Figure 1).
 2 
 
Figure 1. Linear oxylipins isolated from Dracontium loretence (1 and 2) and Nigricanoside A (3), which 
share the same 3-ene-1,2,5 triol moiety 
 
Unique structure and impressive biological activity of Nigricanoside A 3 (Figure 
1) drew our attention as a synthetic target.
3
 Both Nigricanoside A and oxylipin 1 and 2 
share the same 3-ene-1,2,5 triol moiety. Moreover, our synthetic methodology to access 
differentially protected anti-1,2-diols from  -oxyaldehydes could be very useful in the  
*
Org. lett. 2014, 16, 32.
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synthesis of ether linkages between the fatty acid chains in Nigricanoside A .  Therefore, 
these oxylipins can be used as a model system for the total synthesis of Nigricanoside A. 
Furthermore, isolation chemists were only able to assign relative stereochemistry of the 
C-9 and C-10 chiral centers of oxylipins 1 and 2. But the configuration of the chiral 
center at C-6 has not been determined.
2
 Therefore, such a total synthesis to access all 
possible diastereomers of oxylipins could lead to the absolute stereochemical 
determination of oxylipins isolated from Dracontium loretense.  
Lack of stereoflexibility is one of the common features of all five reported total 
syntheses of this natural product.
4
 Since, the previous syntheses did not lead to an 
unambiguous stereochemical assignment of naturally occurring oxylipins, our goal was to 
develop a stereochemically flexible route to access all the diastereomers of oxylipins so 
as to assign the absolute stereochemistry unambiguously.   
 
Results and Discussion 
 
First generation synthesis 
We envisioned the incorporation of our methodology in the synthesis of anti-1,2-
diols from  -oxyaldehydes (chapter 2) in the total synthesis of oxylipins. -Oxygenation 
of aldehydes via organocatalytic enantioselective oxidative incorporation of TEMPO
5
 
was used to set the first chiral center with the hope of setting the second chiral center 
employing a substrate-controlled Grignard addition (Scheme 1). 
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Scheme 1. Synthesis of enone 12 
 
We could have used the more sterically demanding, expensive tryptophan-based 
chiral imidazolidinone
5d
 as the catalyst in the -oxygenation of decanal 4 for superior 
enantioselectivity. But the lengthy synthesis of the tryptophan-based imidazolidinone  
and  the subsequent enantio-enriching step (chiral enone reduction) in the synthesis 
justified our decision to choose phenylalanine-based imidazolidinones 5, despite their 
moderate enantioselectivity in α-oxygenation . Under the oxidative co-catalytic influence 
of CuCl2, imidazolidinone 5 catalyzed the enantioselective -oxygenation of decanal 4 to 
give -oxyaldehyde 6 in 79% yield with 84:14 er (20 mmol scale, 20 mol% loading of 5).  
Lithiation of distanane 7 and addition of lithio intermediate 8 to aldehyde 6 gave an 8:1 
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chromatographically separable mixture of diastereomers of masked 1,2-diol 9 in 89% 
yield. The major product, anti 1,2-diol 9 was isolated in 79% yield without degrading the 
initial enantioselectivity. Moreover, the scalability of this Grignard addition (15 mmol) 
was one of the advantages in the synthesis. Furthermore, careful deoxygenation of 
disatannane 7 was found out be critical for the generation of lithio species 8. Silyl ether 
protection of alcohol 9 followed by Stille cross coupling
6
 with acid chloride 11 gave 
enone 12 in 77% yield over two steps.  
The 1,2-diol technology that we developed (chapter 2) could not generate syn-1,2-
diols directly via chelation control. However, an oxidation-reduction sequence can be 
used to epimerize the free alcohol moiety of anti-1,2-diol 9.  Since polar Felkin-Ahn 
control predominates in this system, hydride addition to the corresponding ketone 13 
should occur from the least hindered side resulting in syn-1,2-diol 14. Upon oxidation, 
alcohol 9 afforded enone 13 in 96% yield.  
Our design plan was to use the Luche reduction
7
 to reliably deliver masked syn 
1,2-diol 14. At 0
 C in MeOH, use of stoichiometric CeCl3 (1 equiv.) in the Luche 
reduction led to better diastereoselectivity and yield than when a catalytic amount of 
CeCl3 (0.2 equiv.) is used (Table 1). However, the 1,4 reduction product was found to be 
the major side product of these reductions. Further, decreasing the temperature to -20
 C 
in MeOH improved the diastereomeric ratio while retaining the former yield. However, 
poor solubility of the enone 13 was observed in MeOH due to the nonpolar tributyltin 
moiety. To address the solubility issue of enone 13 EtOH was used as a solvent. 
Although, enone 13 was completely soluble in EtOH, surprisingly no selectivity was 
observed in the reduction at -20 C (syn:anti 1.2:1),. Since MeOH is an essential 
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component for the retention of a high diastereoselectivity, mixed solvents containing 
MeOH were further screened. The Luche reduction in a MeOH:hexanes (3:1) solvent 
mixture gave a mixture of diastereomers of alcohol 14 in 60% yield, with high dr (13:1). 
However, the Luche reduction in MeOH:THF (3:1) at -20
 C gave alcohol 14 in 70% 
yield with 11:1 dr. Despite the improved yields of the desired product in mixed solvents, 
a major side product was the 1,4 reduced product of enone 13. Due to the high yield, the 
MeOH:THF (3:1) solvent mixture was chosen as the solvent combination for the further 
optimization of the 1,2-reduction of enone. Moreover, to suppress the 1,4 reduction of 
enone 13, CeCl3 loading was raised to 2 equivalents. To our delight conjugate reduction 
of the enone was found to be further suppressed, and the yield of alcohol 14 (82%) was 
increased while improving the diastereoselectivity (18:1). 
 
Table 1. Optimization of Luche reduction of enone 13 
 
 
 
 
 
 
aDetermined by analysis of crude 1H NMR. bCombined yield of both diastereomers, determined by analysis of crude 1H NMR in the 
presence of an internal standard. cIsolated yield of major diastereomer.  
solvent Temp 
(C) 
CeCl3 
(equiv.) 
dra Yieldb (%) 
MeOH 0 0.2 6:1 40 
MeOH 0 1 7:1 55 
MeOH -20 1 10:1 54 
EtOH -20 1 1.2:1 45 
MeOH: hexanes (3:1) -20 1 13:1 60(52)c 
MeOH:THF (3:1) -20 1 11:1 70(62)c 
MeOH:THF (3:1) -20 2 18:1 88(82)
c 
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The silyl protection of alcohol 14 followed by Stille cross coupling with acid 
chloride 11 furnished enone 15 in 84% yield over two steps (Scheme 2).   
 
 
Scheme 2. Synthesis enone 15 
 
Having furnished the carbon back bone, the final chiral center of the natural 
product was planned to be achieved by asymmetric ketone reduction, with the hope of 
further enantio-enrichment. Chiral Me-CBS-oxazoborolidinone ligand with borane-
dimethyl sulfide complex was used in the diastereoselective reduction of enone 12.
8
 
Although, better diastereoselectivity and also better isolated yields were observed for R-
Me-CBS chiral ligand (6:1 dr), poor diastereoselectivity and yield were observed with the 
S-Me-CBS ligand (2:1 dr) due to unfortunate substrate bias (Scheme 3). Zn mediated 
reductive unmasking of the TMP group also deprotected the silyl protecting group in one 
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step to afford a single diastereomer of triol 16 in 59% yield over two steps with enriched 
enantioselectivity (98:2 er). Similarly, a single diastereomer of triol 18 was also obtained 
in 36% yield over two steps and 97:3 er. Basic hydrolysis of methyl esters gave the C-6 
epimeric natural product 17 and 19, which contain the anti-1,2-diol moiety (69% and 
72% yield respectively). Although, our seven step is the shortest synthesis compared to 
the synthesis of related oxylipins containing the anti-1,2-diol moiety, it is tied with 
Kuwahara’s pinellic acid (another class of oxylipin) synthesis9 for the shortest synthesis 
of oxylipins containing the 3-ene-1,2,5-triol moiety.  
 
 
 
Scheme 3. Synthesis of oxylipins with anti 1,2-diol moiety 
 
For the enone 15, optimum diastereoselectivity for the CBS reduction was 
observed when the silyl deprotected enone 20 was used (Scheme 4). Asymmetric 
reductions of enone 20 using R-Me-CBS and S-Me-CBS oxazaborilidinone yielded a 3:1 
and 5:1 mixture of diastereomers which gave a single diastereomer of enol 21 (71% 
yield, 97:3 er) and 23 (51% yield, 96:4 er), respectively. Subsequent reductive cleavage 
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of the TMP masking group followed by ester hydrolysis furnished the C-6 epimeric 
natural products 22 and 24 with syn 1,2-diol moiety (45% and 52% yields over two steps 
respectively). 
 
 
Scheme 4. Synthesis of oxylipins with syn 1,2-diol moiety 
 
After furnishing all the possible diastereomers of oxylipins isolated from 
Dracontium loretense, the stage was set for the assignment of absolute stereochemistry of 
the naturally occurring oxylipins. Comparison of the NMR data taken in methanol and 
optical rotation of our synthetic oxylipins with what is reported by the isolation chemists 
led to the absolute stereochemical determination. The absolute stereochemistry of the 
immunostimulatory natural oxylipin 1 contain anti-1,2-diol moiety  was found to be 
(6R,9S,10R)  and it is the enantiomer of oxylipin 17. Furthermore, the absolute 
stereochemistry of the bio-inactive oxylipins 2 with syn-1,2-diol moiety was found to be 
(6R,9S,10S)-24. Moreover, these naturally occurring oxylipins are C-10 epimers of each 
other. 
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Second generation synthesis 
Our first generation total synthesis of oxylipins was designed with the hope of 
extending the synthetic methodology to access alkyl chains of the Nigricanoside A. The 
presence of alkene moieties in Nigricanoside A did not allow the incorporation of olefin 
metathesis into the model synthesis. Otherwise, our first generation total synthesis of 
oxylipins would have been even shorter. In 2015, Nigricanoside A was synthesized and 
found not to have the previously reported bioactivity. Since we are not interested in 
Nigricanoside A anymore, we redesigned the oxylipin synthesis to become even shorter 
and more efficient by incorporation of convergency via olefin metathesis and by removal 
of additional masking groups. 
In our previous oxylipins synthesis we have used HBF4 salt of phenylalanine 
based chiral imidazolidinone catalyst 5 in organocatalytic, enantioselective -
oxygenation of decanal 4.
10
 Subsequent chiral enhancing step from CBS reduction in the 
oxylipin synthesis and a laborious 5 step synthesis of the tryptophan based sterically 
demanding imidazolidinone 25 led us to use more accessible phenylalanine based chiral 
imidazolidinone 5 despite of the moderate enantioselectivity in the -oxygenation. Our 
significantly shorter oxylipins synthesis and the demand for superior enantioselectivity in 
the -oxygenation step, led us to consider a more sterically demanding chiral 
imidazolidinone catalyst 25 despite its multi-step synthesis.
5d
 Salts of tryptophan-based 
chiral imidazolidinone 25 were our default choice because it is the optimum catalyst in 
MacMillan’s aldehyde -oxygenation.5d  Also, recently our group has successfully 
employed this tryptophan-based chiral imidazolidinone 25 as the catalyst in the 
enantiomeric enrichment in catalytic, enantioselective ,,-trioxygenation of enals.11 
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The HBF4 salt of the tryptophan-based imidazolidinones 25 in acetone at -10 C gave 
superior enantioselectivity and yield compared to phenylalanine-based imidazolidinone 5 
(Table 2). Fast reaction rates (20 mol% of 25, 6 hours), high yields, and the lengthy 
synthesis of catalyst 25 encouraged us to screen lower catalyst loadings. It was found that 
the catalyst loading can be lowered up to 5 mol% when using imidazolidinones 25 with 
no meaningful decrease in enantioselectivity (89:11 er) or yield. Screening lower 
temperature revealed that enantioselectivity at 5 mol% catalyst loading can be further 
improved when the temperature was lowered to   -10 C. At this catalyst loading, the 
yield suffered when the temperature was decreased further. Further decreasing the 
catalyst loading to 2 mol% at 0 C decreased the yield significantly but highest turnover 
number (40.0) for the catalyst was observed while retaining the enantioselectivity. 
Further lowering of temperature to -10 C at 2 mol% catalyst loading decreased the yield 
although the excellent enantioselectivity was retained. 
Diol 26 was synthesized in 75% yield with high diastereoselectivity
10
 after vinyl 
Grignard addition to aldehyde 6 and reductive cleavage of the TMP masking group 
(Scheme 5). 
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Table 2: Optimization of α-oxygenationa 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a2 mmol scale. bIsolated yield. cDetermined by chiral HPLC analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 5. Two step synthesis of diol 27 
R cat. loading temp (C) yield
b
 (%)
 
er
c 
turnover number 
5
 
20 -10 90 88:12 4.5 
25 20 0 96 92:8 4.8 
25 10 0 94
 
88:12 9.4 
25 5 0 92 89:11 18.4 
25 5 -10 94
 
92:8 18.8 
25 2 0 80 91:9 40.0 
25 2 -10 66 92:8 33.0 
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Among the methods
12-14
 used
 
to access allylic alcohol 28 in literature, we explored 
the enantioselective vinyl bromide addition to methyl-6-oxohexanoate mediated by chiral 
methylephedrines. Since the vinyl bromide additions did not lead to promising results, we 
chose enantioselective ketone reductions to furnish allylic alcohol 28. A Stille cross 
coupling between tributylvinylstannane and acid chloride 11 followed by 
diastereoselective reduction of enone 27 using BH3.THF and R-Me-CBS-
oxazoborolidinone as the chiral ligand furnished allylic alcohol 28 in 92:8 er and 67%  
yield in two steps (Scheme 6). The 1,4 conjugate addition product of enone 28 was the 
major product in other enone chiral reduction including Noyori reduction
13
 and chiral 
hydride reductions mediated by chelating BINOL ligands.
15  
 
 
Scheme 6. Two step synthesis of allylic alcohol 28 
 
Having both alkene partners in hand, the stage was set for the olefin metathesis to 
construct the carbon back bone of the natural product. As secondary allylic alcohols both 
alkene partners 26 and 28 are expected behave as type II alkenes. The olefin metathesis 
was expected to be challenging because their homodimers are sparingly consumable.
16
 
Surprisingly, under olefin metathesis conditions allylic alcohol 28 was found to behave as 
a type I alkene, undergoing rapid homodimerization, though alkene  26 behaved as a type 
II alkene as expected. However, chromatographic purification of the desired adduct from 
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homodimers was a nightmare when allylic alcohol 28 was used in excess. Therefore, diol 
26 which is made in high yields in catalytic steps was used in excess in the olefin 
metathesis to address the purification issue. Olefin metathesis between alkene 26 and 28 
followed by in situ ester hydrolysis furnished a single diastereomer of oxylipins 17 in 
53% yield (98:2 er) (Scheme 7). Our current three step synthesis is the shortest and most 
efficient (33% overall yield) route to any oxylipin with the 3-ene-1,2,5-triol moiety. 
 
 
 
 
 
 
 
 
Scheme 7. Synthesis of oxylipin 17 via olefin metathesis 
 
Conclusion 
In conclusion, we further improved the Macmillan’s existing protocol for 
enantioselective organocatalytic -oxygenation of simple aldehydes by optimizing the 
reaction to utilize lower catalyst loadings. Our 5 mol % loading (i.e. one fourth of the 
organocatalyst loading compared to Macmillan’s condition) of chiral imidazolidinones is 
the lowest ever reported loading in the oxidative incorporation of TEMPO in 
organocatalytic α-oxygenation with excellent yield and ee. 
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Utilizing our anti-1,2-diol technology, all possible diastereomers of oxylipins 
isolated from Dracontium loretense were synthesized in our first generation synthesis. 
Moreover, our total synthesis led to an unambiguous stereochemical assignment of the 
natural oxylipins. Incorporation of olefin cross metathesis in the convergent synthesis led 
to an efficient 3-step second generation synthesis, which is not only the shortest but also 
the synthesis with highest overall yield of oxylipins containing the 3-ene-1,2,5 triol 
moiety. 
Experimental 
General procedures 
Unless otherwise noted, all reactions were performed with stirring under an argon 
atmosphere under anhydrous conditions. Organomagnesium and -lithium reagents were 
purchased from Aldrich. All other reagents were purchased at the most-economical 
grade. Dry tetrahydrofuran (THF), N,N-dimethylformamide (DMF), dichloromethane, 
and toluene were obtained by passing HPLC grade solvents through commercial solvent 
purification systems. All other chemicals were used as received, without purification. 
Flash column chromatography was performed using Grace Davison Davisil silica gel (60 
Å, 35 – 70 m). Unless otherwise noted, yields refer to chromatographically- and 
spectroscopically- (
1
H NMR) homogeneous samples of single diastereomers. Thin-layer 
chromatography (TLC) was performed on Grace Davison Davisil silica TLC plates using 
UV light and common stains for visualization. NMR spectra were calibrated using 
residual undeuterated solvent as an internal reference. Apparent couplings were 
determined for multiplets that could be deconvoluted visually. 
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Compounds of first generation synthesis 
 
 
Scheme 8. Synthesis of eneone 12 and 20 
 
 
 -Oxyaldehyde 6: To a mixture of activated 4 Å molecular 
sieves (500 mg, powdered) and imidazolidinone catalyst 5 
(1.22 g, 4 mmol, 0.2 equiv.) in 12 mL acetone was added 
CuCl2·2H2O (340 mg, 2 mmol, 0.1 equiv.). The green reaction mixture was stirred open 
to air for 5 minutes until the copper salt dissolved and the mixture turned dark orange. 
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The reaction was cooled to 0 °C for 10 minutes, then decanal (4; 3.92 mL, 20 mmol, 1.0 
equiv.) was added dropwise over 2 minutes. The reaction was stirred at 0 °C for 10 
minutes, then a solution of TEMPO (3.75 g, 24 mmol, 1.2 equiv.) in 6 mL of acetone was 
added dropwise over 3 minutes. The reaction mixture was capped with a rubber septum 
and an air inlet line was attached via an 18-gauge needle. The reaction was stirred at 0 °C 
for 24 hours, then partitioned between ether (50 mL) and saturated NH4Cl (150 mL). The 
aqueous layer was extracted with ether (2 × 150 mL) and the combined organic layers 
were washed with brine (300 mL). The organic layer was dried over Na2SO4, filtered, and 
concentrated to give an orange oil. Flash column chromatography (3 % EtOAc / hexanes) 
gave -oxyaldehyde 6 (4.83 g, 77 % yield) as a colorless oil. A sample was derivatized 
[1. NaBH4, MeOH; 2. m-nitrobenzoyl chloride, Et3N, DMAP (cat.), CH2Cl2; 3. Zn, 
AcOH, THF, H2O] and determined by chiral HPLC [Chiraltech IC column, 2.1 × 100 
mm, 3 m; 10 % iPrOH / hexanes, 0.2 mL / min, 25 °C; 280 nm UV detection; Rt = 10.7 
(major), 12.3 (minor) minutes] to have 86:14 er. Another sample was converted into (S)-
1,2-decanediol (1. NaBH4, MeOH; 2. Zn, AcOH, THF, H2O) and its optical rotation was 
compared with that of the commercial substance in order to confirm the absolute 
configuration. 6: Rf = 0.37 (5 % EtOAc / hexanes); []D
23
 = −102.5 ° (c = 1.00, CHCl3); 
IR (thin film): max = 2931, 1727 cm
–1
; 
1
H NMR (600 MHz, CDCl3):  = 9.77 (d, J = 4.5 
Hz, 1H), 4.07 (dt, J = 9.8, 5.0 Hz, 1H), 1.73 (m, 1H), 1.65 (m, 1H), 1.48 – 1.41 (m, 4H), 
1.37 – 1.22 (m, 14H), 1.20 – 1.10 (m, 12H), 0.88 (t, J = 7.0 Hz, 3H) ppm; 13C NMR (150 
MHz, CDCl3):  = 204.8, 88.7, 60.7, 59.8, 40.3, 34.5, 33.9, 32.0, 30.1, 29.8, 29.5, 29.3, 
24.4, 22.8, 20.5, 20.4, 17.3, 14.2 ppm; HRMS (ESI-QTOF) calcd for C19H38NO2
+
 [M + 
H
+
]: 312.2903, found: 312.2904. 
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Vinylstannane 9: To a deoxygenated solution        
(3×freeze–pump–thaw) of trans-1,2-
bis(tributylstannyl)ethene (7; 16.4 g, 27 mmol, 1.8 
equiv.) in 50 mL of THF at 0 °C was added nBuLi (2.5 M in hexanes, 10.8 mL, 27 mmol, 
1.8 equiv.) dropwise over 5 minutes. The resultant yellow solution was stirred at 0 °C for 
30 minutes, cooled to –78 °C, then transferred by cannula to a deoxygenated solution (3 × 
freeze–pump–thaw) of aldehyde 9 (4.67 g, 15 mmol, 1.0 equiv.) in 15 mL of THF at –78 
°C. The reaction was warmed to ambient temperature by removing the cooling bath, then 
partitioned between saturated NH4Cl (50 mL) and EtOAc (50 mL). The organic phase 
was washed with water (2 × 50 mL) and brine (50 mL), dried over Na2SO4, and 
concentrated to give a yellow oil. Flash column chromatography (2 % ether / hexanes) 
gave vinylstannane 9 (7.43 g, 79 % yield) as a colorless oil as well as epimeric 
vinylstannane 14 contaminated with a trace of vinylstannane 9 (752 mg, 8 % yield). A 
small sample was elaborated to oxylipin (6R,9S,10S)-17 using a Luche reduction 
(NaBH4, CeCl3, MeOH) instead of a CBS reduction and determined to have 86:14 er. 9: 
Rf = 0.35 (5 % EtOAc / hexanes); []D
23
 = +16.4 ° (c = 1.34, CHCl3); IR (thin film): max 
= 3683, 3019, 2928, 1465 cm
–1
; 
1
H NMR (600 MHz, CDCl3):  = 6.19 (dd, J = 19.1, 1.0 
Hz, 1H), 6.08 (dd, J = 19.2, 5.6, 1H), 4.39 (td, J= 5.0, 1.3 Hz, 1H), 3.98 (m, 1H), 2.47 (d, 
J = 6.9 Hz, 1H), 1.80 (m, 1H), 1.60 – 1.41 (m, 11H) 1.39 – 1.20 (m, 23H), 1.16 – 1.09 
(m, 9H), 0.88 (m, 18H) ppm; 
13
C NMR (150 MHz, CDCl3):  = 147.2, 129.2, 84.7, 76.3, 
60.3, 40.8, 34.5, 32.0, 30.3, 29.7, 29.5, 29.3, 29.0, 27.5, 26.7, 22.8, 20.8, 20.6, 17.4, 14.3, 
13.8, 9.6 ppm; HRMS (ESI-QTOF) calcd for C33H68NO2Sn
+
 [M + H
+
]: 630.4272, found: 
630.4308.  
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Enone 13: To a solution of vinylstannane 9 (654 mg, 
1.04 mmol, 1.0 equiv.) in 3 mL of THF was added a 
solution of IBX (378 mg, 1.36 mmol, 1.3 equiv.) in 1 
mL of DMSO. The reaction mixture was stirred for 1.5 hours, then diluted with 50 mL of 
ether and filtered. The organic phase was washed with water (3 × 50 mL) and brine (30 
mL), dried over Na2SO4, and concentrated to give enone 13 (627 mg, 96 %) as a yellow 
oil. 13: Rf = 0.46 (5 % EtOAc / hexanes); []D
23
 = –88.2 ° (c = 1.00, CHCl3); IR (thin 
film): max = 2927, 1697, 1464 cm
–1
; 
1
H NMR (600 MHz, CDCl3):  = 7.77 (d, J = 19.5 
Hz, 1H), 6.99 (d, J = 19.5 Hz, 1H), 4.28 (dd, J = 9.9, 3.8 Hz, 1H), 1.89 (m, 1H), 1.74 (m, 
1H), 1.59 – 1.06 (m, 39H), 1.04 – 0.91 (m, 9H), 0.87 (m, 12H) ppm; 13C NMR (150 
MHz, CDCl3):  = 198.8, 150.9, 142.2, 90.6, 59.8, 40.5, 34.0, 32.3, 32.0, 29.8, 29.5, 29.3, 
29.2, 27.4, 24.5, 22.8, 20.4, 20.3, 17.3, 14.2, 13.8, 9.9 ppm; HRMS (ESI-QTOF) calcd 
for C33H66NO2Sn
+
 [M + H
+
]: 628.4116, found: 628.4116.  
 
Allylic alcohol 14. To a solution of enone 13 (700 mg, 
1.11 mmol, 1.0 equiv.) in 2.7 mL of THF and 8.3 mL 
of MeOH was added CeCl3·7H2O (834 mg, 2.24 mmol, 
2.0 equiv.). The reaction mixture was stirred for 15 minutes, then cooled to –20 °C. 
NaBH4 (43 mg, 1.11 mmol, 1.0 equiv.) was added, and since TLC analysis showed 
remaining enone 13 additional NaBH4 (22 mg, 0.56 mmol, 0.5 equiv.) was added. The 
reaction mixture was partitioned between ether (50 mL) and water (100 mL). The 
aqueous layer was extracted with ether (100 mL), and the combined organic layers were 
washed with brine (50 mL), dried over Na2SO4, and concentrated to give a colorless oil. 
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Flash column chromatography (2 % ether / hexanes) gave allylic alcohol 14 (573 mg, 82 
% yield) as a colorless oil as well as epimeric allylic alcohol 9 (43 mg, 6 % yield). A 
small sample was elaborated to oxylipin (6R,9S,10S)-24 using a Luche reduction 
(NaBH4, CeCl3, MeOH) instead of a CBS reduction and determined to have 86:14 er. 14: 
Rf = 0.34 (5 % EtOAc / hexanes); []D
23
 = –20.0 ° (c = 1.00, CHCl3); IR (thin film): max 
= 3576, 3018, 2925, 1465 cm
–1
; 
1
H NMR (600 MHz, CDCl3):  = 7.48 (br s, 1H), 6.27 (d, 
J = 19.0 Hz, 1H), 5.87 (dd, J = 18.9, 6.4 Hz, 1H), 4.31 (t, J = 7.6 Hz, 1H), 3.87 (dt, J = 
8.4, 2.5 Hz, 1H), 1.63 – 1.24 (m, 38H), 1.18 (br s, 3H), 1.13 (br s, 3H), 0.88 (t, J = 7.5 
Hz, 18H) ppm; 
13
C NMR (150 MHz, CDCl3):  = 147.5, 131.0, 82.8, 80.8, 61.8, 60.2, 
40.5, 40.0, 34.6, 32.1, 32.0, 31.4, 30.0, 29.6, 29.4, 29.2, 27.4, 25.6, 22.8, 17.3, 14.2, 13.8, 
9.6ppm; HRMS (ESI-QTOF) calcd for C33H68NO2Sn
+
 [M + H
+
]: 630.4272, found: 
630.4286. 
 
Silyl ether 10: To a solution of alcohol 9 (1.25 g, 2 
mmol, 1.0 equiv.) and imidazole (204 mg, 3 mmol, 1.5 
equiv.) in 8 mL of DMF was added TESCl (402 µL, 
2.4 mmol, 1.2 equiv.) dropwise over 2 minutes. The reaction mixture was stirred for 45 
minutes, then partitioned between water (50mL) and ether (100 mL). The organic phase 
was washed with water (3 × 50 mL) and brine (50 mL), dried over Na2SO4, and 
concentrated to give a colorless oil. Flash column chromatography (1 % ether / hexanes) 
gave silyl ether 10 (1.48 g, 86 % yield) as a colorless oil. 10: Rf = 0.56 (5 % EtOAc / 
hexanes); []D
23
 = –17.0 ° (c = 1.00, CHCl3); IR (thin film): max = 3054, 2957, 1421 cm
–
1
; 
1
H NMR (600 MHz, CDCl3):  = 6.10 (dd, J = 19.0, 6.8 Hz, 1H), 6.03 (d, J = 19.2 Hz, 
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1H), 4.20 (dd, J = 6.4, 2.7 Hz, 1H), 3.83 (m, 1H), 1.94 (m, 1H), 1.62 – 1.13 (m, 37H), 
1.07 (m, 6H), 0.95 (t, J = 7.9 Hz, 9H), 0.88 (t, J = 7.4 Hz , 18H), 0.59 (q, J = 7.8 Hz, 6H) 
ppm; 
13
C NMR (150 MHz, CDCl3):  = 149.4, 128.6, 86.3, 79.3, 60.9, 59.4, 40.6, 34.6, 
32.1, 30.4, 30.1, 29.8, 29.5, 29.4, 27.5, 27.0, 22.9, 20.8, 17.5, 14.3, 13.9, 9.6, 7.1, 5.4 
ppm; HRMS (ESI-QTOF) calcd for C39H82NO2SnSi
+
 [M + H
+
]: 744.5137, found: 
744.5185. 
 
Silyl ether 14’: was prepared in the same manner as 
TES ether 10. Flash column chromatography (1 % 
EtOAc / hexanes) gave a colorless oil that was 
contaminated with TESOH. 
 
Enone 12: To a deoxygenated solution (3 × 
freeze–pump–thaw) of vinylstannane 10 
(1.27 g, 1.7 mmol, 1.0 equiv.), PCy3·HBF4 
(31 mg, 85 mol, 0.05 equiv.), iPr2NEt (15 L, 85 mol, 0.05 equiv.), and Pd2(dba)3 (38 
mg, 43 mol, 0.025 equiv.) in 34 mL of toluene was added acid chloride 11 (528 L, 3.4 
mmol, 2.0 equiv.) dropwise over 2 minutes. The reaction mixture was heated at 50 °C for 
45 minutes, then cooled and diluted with 75 mL EtOAc. The organic phase was washed 
with 3 % aq. NH4OH (85 mL), water (2 × 75 mL), and brine (75 mL), dried over Na2SO4, 
and concentrated to give a yellow oil. Flash column chromatography (8 % EtOAc / 
hexanes) gave enone 12 (914 mg, 89 % yield) as a colorless oil. 12: Rf = 0.36 (10 % 
EtOAc / hexanes); []D
23
 = +21.0 ° (c = 1.10, CHCl3); IR (thin film): max = 3022, 2929, 
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1733, 1670 cm
–1
; 
1
H NMR (600 MHz, CDCl3):  = 6.91 (dd, J = 16.1, 5.9 Hz, 1H), 6.20 
(dd, J = 16.0, 1.4 Hz, 1H), 4.40 (ddd, 5.8, 2.6, 1.4 Hz, 1H), 3.91 (m, 1H), 3.67 (s, 3H), 
2.59 (m, 2H), 2.33 (m, 2H), 2.03 (m, 1H), 1.70 – 1.62 (m, 4H), 1.51 – 1.37 (m, 4H), 1.35 
– 1.23 (m, 15H), 1.19 (br s, 3H), 1.15 (br s, 3H), 1.05 (br s, 3H), 1.03 (br s, 3H), 0.96 (t, 
8.0 Hz, 9H), 0.88 (t, 6.9 Hz, 3H), 0.60 (q, 7.9 Hz, 6H) ppm; 
13
C NMR (150 MHz, 
CDCl3):  = 200.3, 174.0, 147.3, 129.3, 86.3, 74.6, 61.0, 59.4, 51.6, 40.7, 40.4, 39.5, 34.6, 
34.4, 34.0, 32.0, 30.21, 30.17, 29.7, 29.4, 27.0, 24.7, 23.8, 22.8, 20.8, 20.6, 17.4, 14.2, 7.0, 
5.1 ppm; HRMS (ESI-QTOF) calcd for C34H66NO5Si
+
 [M + H
+
]: 596.4705, found: 
596.4704. 
 
Enone 15 was prepared in the same 
manner as enone 12. Flash column 
chromatography (8 % EtOAc / hexanes) 
gave enone 15 (84 % yield over two steps) as a colorless oil. 15: Rf = 0.38 (10 % EtOAc / 
hexanes); []D
23
 = −60.0 ° (c = 1.00, CHCl3); IR (thin film): max = 3022, 2955, 1737, 
1695, 1678, 1458 cm
–1
; 
1
H NMR (600 MHz, CDCl3):  = 7.02 (dd, J = 15.9, 3.6 Hz, 1H), 
6.32 (d, J = 15.9 Hz, 1H), 4.70 (m, 1H), 3.86 (m, 1H), 3.67 (s, 3H), 2.60 (m, 2H), 2.34 
(m, 2H), 1.66 (m, 5H), 1.58 – 1.18 (m, 19H), 1.12 (br s, 12H), 0.96 (t, J = 8.0 Hz, 9H), 
0.88 (t, J = 7.0 Hz, 3H), 0.61 (q, J = 7.9 Hz, 6H) ppm; 
13
C NMR (150 MHz, CDCl3):  = 
200.1, 174.0, 147.8, 129.1, 85.3, 72.3, 60.2, 51.6, 40.8, 39.8, 34.0, 32.0, 30.2, 29.7, 29.4, 
26.9, 24.7, 23.8, 22.8, 20.6, 17.4, 14.2, 7.0, 5.0 ppm; HRMS (ESI-QTOF) calcd for 
C34H66NO5Si
+
 [M + H
+
]: 596.4705, found: 596.4712. 
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Alcohol 20: To a solution of silyl ether 15 
(380 mg, 0.64 mmol, 1.0 eqiv.) in 2.5 mL 
of THF was added TBAF (1.0 M in THF, 
1.92 mL, 1.92 mmol, 3.0 equiv) over 2 minutes. The reaction mixture was stirred for 10 
minutes, then partitioned between water (20mL) and EtOAc (20 mL). The organic phase 
was washed with water (3 × 10 mL) and brine (10 mL), dried over Na2SO4, and 
concentrated to give a colorless oil. Flash column chromatography (13 % EtOAc / 
hexanes) gave alcohol 20 (256 mg, 84 % yield) as a colorless oil. 20: Rf = 0.26 (20 % 
EtOAc / hexanes); []D
23
 = −24.0 ° (c = 1.00, CHCl3); IR (thin film): max = 3674, 3054, 
2929, 1695, 1677, 1633 cm
–1
; 
1
H NMR (600 MHz, CDCl3):  = 7.86 (br s, 1H), 6.72 (dd, 
J = 15.7, 5.1 Hz, 1H), 6.45 (d, J = 15.8 Hz, 1H), 4.57 (m, 1H), 3.89 (m, 1H), 3.66 (s, 
3H), 2.57 (m, 2H), 2.33 (m, 2H), 1.67 – 1.63 (m, 4H), 1.54 – 1.22 (m, 26H), 1.19 (br s, 
3H), 1.14 (br s, 3H), 0.88 (t, J = 7.0 Hz, 3H), ppm; 
13
C NMR (150 MHz, CDCl3): δ = 
199.8, 173.9, 144.2, 129.7, 82.7, 76.2, 62.0, 60.4, 51.6, 40.8, 40.5, 40.0, 34.6, 34.0, 31.99, 
31.95, 31.3, 29.9, 29.6, 29.4, 25.4, 24.6, 23.5, 22.8, 20.72, 20.66, 17.2, 14.2 ppm; HRMS 
(ESI-QTOF) calcd for C28H52NO5
+
 [M + H
+
]: 482.3840, found: 482.3844. 
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Scheme 9. Synthesis of oxylipins 
 
 
Allylic alcohol 12’: To a solution of enone 
12 (200 mg, 0.34 mmol, 1.0 equiv.) in 150 
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L of THF at −78 °C was added a pre-mixed solution of (R)-Me-CBS (122 mg, 0.44 
mmol, 1.3 equiv.) and BH3·SMe2 (2 M in THF, 220 L, 0.44 mmol, 1.3 equiv.) dropwise 
over 1 minute. After 5 minutes the reaction mixture was warmed to 0 °C and quenched 
by adding 50 L of methanol and   10 L of 4 N HCl. After stirring at ambient 
temperature for 30 minutes, the reaction mixture was diluted with EtOAc (10mL). The 
organic layer was washed with water (2 × 10 mL), brine (10 mL), and saturated NaHCO3 
(10 mL), dried over Na2SO4, and concentrated to give a yellow oil as a 5.7:1 mixture of 
diastereomers. Flash column chromatography (40 % EtOAc / hexanes) gave allylic 
alcohol 12’ as a mixture of diastereomers that was a colorless oil. A sample was 
converted into methyl (S)-6,7-dihydroxyheptanoate (1. O3, MeOH, THF; then Me2S; 2. 
NaBH4, EtOH) and its optical rotation was compared with that of the known substance in 
order to confirm the absolute configuration. 
 
Allylic alcohols 12” – 26 were prepared in the same manner as allylic alcohol 12’.  
 
 
Allylic alcohol 12”: Flash column 
chromatography (40 % EtOAc / hexanes) 
gave allylic alcohol 12” (2.0:1 mixture of 
diastereomers) as a colorless oil. 
Allylic alcohol 21: Flash column 
chromatography (40 % EtOAc / CHCl3) 
gave allylic alcohol 21 in 68 % yield as a 
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colorless oil and epimeric alcohol 23 in 13 % yield. A small sample of allylic alcohol 21 
was purified for characterization. 21: Rf = 0.38 (40 % EtOAc / CHCl3); []D
23
 = −40.4 ° 
(c = 1.00, CHCl3); IR (thin film): max = 3457, 3014, 2924, 1729 cm
–1
; 
1
H NMR (600 
MHz, CDCl3):  = 7.66 (br s, 1H), 5.80 (dd, J = 15.4 Hz, 6.0 Hz, 1H), 5.59 (dd, J = 15.4 
Hz, 6.7 Hz, 1H), 4.35 (t, J = 7.7 Hz, 1H), 4.13 (m, 1H), 3.86 (t, J = 8.2 Hz, 1H), 3.66 (s, 
3H), 2.31 (t, J = 7.5 Hz, 2H), 1.78 – 1.20 (m, 33H), 1.17 (s, 3H), 1.12 (s, 3H), 0.87 (t, J = 
6.8 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3):  =  174.3, 135.6, 130.0, 82.9, 72.1, 61.9, 
60.3, 51.6, 40.5, 40.0, 36.9, 34.6, 34.1, 32.1, 32.0, 31.4, 30.0, 29.7, 29.4, 25.6, 25.1, 25.0, 
22.8, 20.74, 20.67, 17.3, 14.2 ppm; HRMS (ESI-QTOF) calcd for C28H54NO5
+
 [M + H
+
]: 
484.3997, found: 484.4002. 
 
Allylic alcohol 23: Flash column 
chromatography (40 % EtOAc / CHCl3) 
gave allylic alcohol 23 in 51 % yield as a 
colorless oil, epimeric alcohol 21 in 7 % yield, and a mixture of the two epimers in 7 % 
yield. 23: Rf = 0.33 (40 % EtOAc / hexanes); []D
23
 = −20.2 ° (c = 1.00, CHCl3); IR (thin 
film): max = 3357, 3924, 1739 cm
–1
; 
1
H NMR (600 MHz, CDCl3):  = 7.70 (br s, 1H), 
5.80 (dd, J = 15.6 Hz, 7.0 Hz, 1H), 5.58 (dd, J = 15.4 Hz, 6.8 Hz, 1H), 4.36 (t, J = 7.7 
Hz, 1H), 4.11 (m, 1H), 3.88 (t, J = 8.2 Hz, 1H), 3.66 (s, 3H), 2.30 (t, J = 7.5 Hz, 2H), 
1.70 – 1.20 (m, 33H), 1.18 (s, 3H), 1.13 (s, 3H), 0.88 (t, J = 7.0 Hz, 3H) ppm; 13C NMR 
(150 MHz, CDCl3):  =  174.2, 135.5, 130.5, 83.0, 72.5, 51.6, 40.5, 40.0, 36.9, 34.59, 34.56, 
34.1, 32.0, 31.5, 30.0, 29.7, 29.4, 25.5, 25.2, 25.0, 22.8, 20.8, 20.7, 17.3, 14.2 ppm; HRMS 
(ESI-QTOF) calcd for C28H54NO5
+
 [M + H
+
]: 484.3997, found: 484.4002. 
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Triols 16, 18, 21’ and 23’ were prepared in the same manner as diol 12 of chapter 2.  
 
Triol 16: Flash column chromatography 
(85 % EtOAc / hexanes) gave triol 16 (59 
% yield over two steps) as a white solid as 
well as epimeric triol 18 (11 % yield). A 98:2 er was established after saponification to 
oxylipin (6S,9R,10S)-16. 15: Rf = 0.21 (80 % EtOAc / hexanes); []D
23
 = +8.2 ° (c = 0.6, 
MeOH); IR (thin film): max = 3332, 2920, 2844, 1732, cm
–1
; 
1
H NMR (600 MHz, 
CD3OD):  = 5.73 (dd, J = 15.6 Hz, 6.3 Hz, 1H), 5.67 (dd, J = 15.8 Hz, 6.4 Hz, 1H), 4.05 
(q, J = 6.3 Hz, 1H), 3.92 (dd, J = 6.3 Hz, 4.7 Hz, 1H), 3.65 (s, 3H), 3.49 (m, 1H), 2.33 (t, 
J = 7.4 Hz, 2H), 1.63 (m, 2H), 1.59 – 1.26 (m, 18H), 0.90 (t, J = 7.0 Hz, 3H) ppm; 13C 
NMR (150 MHz, CD3OD):  = 175.9, 136.4, 131.0, 76.5, 75.7, 73.0, 52.0, 38.0, 34.8, 
33.8, 33.1, 30.9, 30.7, 30.4, 27.0, 26.1, 26.0, 23.7, 14.4 ppm; ppm; HRMS (ESI-QTOF) 
calcd for C19H36O5Na
+
 [M + Na
+
]: 367.2460, found: 367.2455. 
 
 Triol 18: Flash column chromatography 
(85 % EtOAc / hexanes) gave triol 18 (36 
% yield over two steps) as a white solid as 
well as epimeric triol 16 (23 % yield). 18: Rf = 0.26 (80 % EtOAc / hexanes); []D
23
 = 
−6.8 ° (c = 0.25, MeOH); IR (thin film): max = 3278, 2929, 2847, 1730 cm
–1
; 
1
H NMR 
(600 MHz, CD3OD):  = 5.73 (dd, J = 15.7 Hz, 6.1 Hz, 1H), 5.69 (dd, J = 15.6 Hz, 5.9 
Hz, 1H), 4.06 (q, J = 6.0 Hz, 1H), 3.92 (t, J = 5.4 Hz, 1H), 3.65 (s, 3H), 3.47 (m, 1H), 
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2.33 (t, J = 7.4 Hz, 2H), 1.63 (m, 2H), 1.57 – 1.20 (m, 18H), 0.90 (t, J = 7.0 Hz, 3H) 
ppm; 
13
C NMR (150 MHz, CD3OD):  =175.9, 136.4, 131.1, 76.5, 75.7, 72.9, 52.0, 37.9, 
34.8, 33.6, 33.1, 30.9, 30.7, 30.5, 27.0, 26.1, 26.0, 23.7, 14.4 ppm; ppm; HRMS (ESI-
QTOF) calcd for C19H36O5Na
+
 [M + Na
+
]: 367.2460, found: 367.2464. 
 
Triol 21’: Flash column chromatography 
(85 % EtOAc / hexanes) gave triol 21’ (64 
% yield) as a white solid. 21’: Rf = 0.36 (80 
% EtOAc / hexanes); []D
23
 = −11.4° (c = 0.50, MeOH); IR (thin film): max = 3357, 
3313, 2924, 2841, 1739 cm
–1
; 
1
H NMR (600 MHz, CD3OD):  = 5.70 (m, 2H), 4.05 (q, J 
= 6.1 Hz, 1H), 3.90 (t, J = 5.6 Hz, 1H), 3.65 (s, 3H), 3.41 (m, 1H), 2.33 (t, J = 7.5 Hz, 
2H), 1.63 (m, 2H), 1.58 – 1.25 (m, 18H), 0.90 (t, J = 6.22, 3H) ppm; 13C NMR (150 
MHz, CD3OD):  =  175.9, 136.4, 131.2, 76.5, 75.8, 72.8, 52.0, 38.0, 34.8, 33.6, 33.1, 
30.9, 30.7, 30.5, 26.9, 26.1, 26.0, 23.7, 14.4 ppm; HRMS (ESI-QTOF) calcd for 
C19H36O5Na
+
 [M + Na
+
]: 367.2460, found: 367.2461. 
 
Triol 23’: Flash column chromatography 
(85 % EtOAc / hexanes) gave triol 23’ (71 
% yield) as a white solid. 23’: Rf = 0.29 (80 
% EtOAc / hexanes); []D
23
 = −36.3° (c = 0.30, MeOH); IR (thin film): max = 3537, 
3313, 2924, 2841, 1739 cm
–1
; 
1
H NMR (600 MHz, CD3OD):  = 5.70 (dd, J = 15.6 Hz, 
6.0 Hz, 1H), 5.65 (dd, J = 15.6 Hz, 6.2 Hz, 1H), 4.04 (q, J = 6.4 Hz, 1H), 3.88 (t, J = 6.1 
Hz, 1H), 3.65 (s, 3H), 3.40 (m, 1H), 2.33 (t, J = 7.4 Hz, 2H), 1.63 (m, 2H), 1.59 – 1.21 
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(m, 18H) 0.90 (t, J = 6.4 Hz, 3H) ppm; 
13
C NMR (150 MHz, CD3OD):  = 175.9, 136.6, 
131.4, 76.6, 75.7, 72.9, 52.0, 37.9, 34.8, 33.8, 33.1, 30.9, 30.7, 30.4, 26.8, 26.1, 26.0, 
23.8, 14.5 ppm; HRMS (ESI-QTOF) calcd for C19H36O5Na
+
 [M + Na
+
]: 367.2460, found: 
367.2460. 
Oxylipin (6S,9R,10S)-17: To a solution of 
triol 16 (20 mg, 0.056 mmol, 1.0 equiv.) in 
THF (2.7 mL) was added 0.3 mL of an 
aqueous 1.0 M LiOH solution over one minute. The reaction mixture was stirred 
overnight, then partitioned between EtOAc (5 mL) and 1 N HCl (5 mL). The organic 
phase was washed with water (2 × 5 mL) and brine (5 mL), dried over Na2SO4, and 
concentrated to give a white solid. Flash column chromatography (0 – 10 % MeOH / 
EtOAc) gave oxylipin (6S,9R,10S)-17 (13 mg, 69 % yield) as a white solid. A sample 
was derivatized (p-nitrobenzyl amine·HCl, BOP–BF4, HOBt, iPr2NEt, DMF) and 
determined by chiral HPLC [Chiraltech IC column, 2.1 × 100 mm, 3 m; 12 % iPrOH / 
hexanes, 0.2 mL / min, 25 °C; 280 nm UV detection; Rt = 11.4 (major), 12.7 (minor) 
minutes] to have 98:2 er. (6S,9R,10S)-17: Rf = 0.29 (100 % EtOAc); []D
23
 = +4.4 ° (c = 
0.9, MeOH); IR (thin film): max = 3386, 3019, 2941, 1712 cm
–1
; 
1
H NMR (600 MHz, 
CD3OD):  = 5.73 (dd, J = 15.6 Hz, 6.4 Hz, 1H), 5.67 (dd, J = 15.6 Hz, 6.2 Hz, 1H), 4.06 
(q, J = 6.2 Hz, 1H), 3.92 (t, J = 5.3 Hz, 1H), 3.49 (m, 1H), 2.29 (t, J = 7.2 Hz, 2H), 1.62 
(m, 2H) 1.59 – 1.22 (m, 18H), 0.90 (t, J = 6.5 Hz, 3H) ppm; 13C NMR (150 MHz, 
CD3OD): δ = 177.7, 136.5, 131.0, 76.5, 75.7, 73.1, 38.0, 35.1, 33.8, 33.1, 30.9, 30.7, 30.4, 
27.0, 26.2, 26.1, 23.7, 14.4 ppm; HRMS (ESI-QTOF) calcd for C18H34O5Na+ [M + Na+]: 
353.2304, found: 353.2301.  
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The other diastereomeric of oxylipins 19, 22 and 24  were prepared in the same manner as 
oxylipin (6S,9R,10S)-17. 
 
Oxylipin (6R,9R,10S)-19: Flash column 
chromatography (0 – 5 % MeOH / EtOAc) 
gave oxylipin (6R,9R,10S)-19 (72 % yield) 
as a white solid. A sample was derivatized (p-nitrobenzyl amine·HCl, BOP–BF4, HOBt, 
iPr2NEt, DMF) and determined by chiral HPLC [Chiraltech IC column, 2.1 × 100 mm, 3 
m; 12 % iPrOH / hexanes, 0.2 mL / min, 25 °C; 280 nm UV detection; Rt = 12.9 
(major), 10.9 (minor) minutes] to have 96:4 er. (6R,9R,10S)-19: Rf = 0.18 (5 % MeOH / 
CHCl3 ); []D
23
 = −14.6 ° (c = 0.15, MeOH); IR (thin film): max = 3312, 2923, 1701 cm
–
1
; 
1
H NMR (600 MHz, CD3OD):  = 5.74 (dd, J = 15.6 Hz, 6.1 Hz, 1H), 5.69 (dd, J = 
15.6 Hz, 6.0 Hz, 1H), 4.06 (q, 6.0 Hz, 1H), 3.92 (t, J = 6.0 Hz, 1H), 3.47 (ddd, J = 9.0, 
4.9, 3.0 Hz, 1H), ), 2.29 (t, J = 7.5 Hz, 2H), 1.62 (m, 2H), 1.59 – 1.23 (m, 18H), 0.90 (t, J 
= 7.0 Hz, 3H) ppm; 
13
C NMR (150 MHz, CD3OD): 136.4, 131.1, 76.6, 75.7, 73.0, 38.0, 
35.1, 33.6, 33.1, 30.9, 30.8, 30.5, 27.0, 26.2, 26.1, 23.7, 14.4.ppm; HRMS (ESI-QTOF) 
calcd for C18H34O5Na
+
 [M + Na
+
]: 353.2304, found: 353.2304. 
 
Oxylipin (6S,9S,10S)-22: Flash column 
chromatography (0 – 5 % MeOH / EtOAc) 
gave oxylipin (6S,9S,10S)-22 (71 % yield) 
as a white solid. A sample was derivatized (p-nitrobenzyl amine·HCl, BOP–BF4, HOBt, 
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iPr2NEt, DMF) and determined by chiral HPLC [Chiraltech IC column, 2.1 × 100 mm, 3 
m; 12 % iPrOH / hexanes, 0.2 mL / min, 25 °C; 280 nm UV detection; Rt = 11.3 
(major), 14.2 (minor) minutes] to have 98:2 er. (6S,9S,10S)-22: Rf = 0.23 (10% MeOH / 
CHCl3); []D
23
 = −21.2 ° (c = 0.25, MeOH); IR (thin film): max = 3338, 2914, 1700 cm
-1
; 
1
H NMR (600 MHz, CD3OD):  = 5.72 (dd, J = 15.6 Hz, 5.6 Hz, 1H), 5.68 (dd, J = 15.6 
Hz, 5.9 Hz, 1H), 4.06 (q, J = 6.1 Hz, 1H), 3.91 (t, J = 5.6 Hz, 1H), 3.42 (m, 1H), 2.28 (t, 
J = 7.4 Hz, 2H), 1.62 (m, 2H), 1.58 – 1.22 (m, 18H), 0.90 (t, J = 7.0 Hz, 3H) ppm; 13C 
NMR (150 MHz, CD3OD):  = 136.3, 131.0, 76.4, 75.6, 72.7, 37.9, 35.3, 33.4, 32.9, 
30.7, 30.6, 30.3, 26.8, 26.1, 26.0, 23.6, 14.3 ppm; HRMS (ESI-QTOF) calcd for 
C18H34O5Na
+
 [M + Na
+
]: 353.2304 found: 353.2302. 
 
Oxylipin (6R,9S,10S)-24: Flash column 
chromatography (0 – 5 % MeOH / EtOAc) 
gave oxylipin (6R,9S,10S)-16 (73 % yield) 
as a white solid. A sample was derivatized (p-nitrobenzyl amine·HCl, BOP–BF4, HOBt, 
iPr2NEt, DMF) and determined by chiral HPLC [Chiraltech IC column, 2.1 × 100 mm, 3 
m; 12 % iPrOH / hexanes, 0.2 mL / min, 25 °C; 280 nm UV detection; Rt = 13.4 
(major), 11.4 (minor) minutes] to have 96:4 er. (6R,9S,10S)-24: Rf = 0.19 (10 % MeOH / 
CHCl3); []D
23
 = −30.4 ° (c = 0.25, MeOH); IR (thin film): max = 3395, 2917, 1686 cm
–
1
; 
1
H NMR (600 MHz, CD3OD):  = 5.71 (dd, J = 15.6 Hz, 6.1 Hz, 1H), 5.66 (dd, J = 
15.6 Hz, 6.3 Hz, 1H), 4.05 (q, J = 6.3 Hz, 1H), 3.88 (t, J = 6.11, 1H), 3.40 (m, 1H), 2.29 
(t, J = 7.5 Hz, 2H), 1.62 (m, 2H), 1.59 – 1.21 (m, 18H), 0.90 (t, J = 6.9 Hz, 3H) ppm; 13C 
NMR (150 MHz, CD3OD):  = 136.6, 131.4, 76.9, 75.6, 72.8, 38.2, 35.0, 33.8, 33.0, 
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30.9, 30.7, 30.4, 26.9, 26.2, 26.1, 23.7, 14.4 ppm; HRMS (ESI-QTOF) calcd for 
C18H34O5Na
+
 [M + Na
+
]: 353.2304, found: 353.2303. 
 
Second generation synthesis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 10. Second generation synthesis of oxylipins
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-Oxyaldehyde 6: Prepared as first generation protocol for          
-Oxyaldehyde 6 using 5 mol% of HBF4 salt of imizazolidinone 
25  at -10 °C.  
 
Diol 26: To a solution of aldehyde 6 (562 mg, 1.80 mmol, 1.0 
equiv.) in 1.80 mL of THF at –78 °C was added 
vinylmagnesium bromide (1.0 M in THF, 2.33 mmol, 1.3 equiv.) dropwise over 3 
minutes. The resultant solution was stirred at –78 °C for 30 minutes, then warmed to 
room temperature and was diluted with 20 mL of a 3:1:1 solvent mixture 
(HOAc:H2O:THF). To the resulting solution was added zinc (1.18 g, 18.0 mmol, 10 
equiv.) and refluxed at 70 °C for 6 hours. After cooling, the reaction mixture was filtered 
through Celite, concentrated, and azeotrope dried with toluene to give a white solid. Flash 
column chromatography (30 % EtOAc / hexanes) gave diol 27 (270 mg, 75 % yield, 
>20:1 mixture diastereomers) as a white solid. 27: Rf = 0.29 (35% EtOAc / hexanes); 
[α]D
23
 = –3.5 ° (c = 1.00, CHCl3); IR (thin film): max = 3305, 3212, 2916, 2849 cm
–1
;
  1
H 
NMR (600 MHz, CDCl3):  = 5.93 (ddd, J = 17.1, 10.6, 6.5 Hz, 1H), 5.34 (td, J = 17.3, 
1.5 Hz, 1H), 5.28 (td, J = 10.5, 1.3 Hz, 1H), 4.10 (m, 1H), 3.69 (td, J = 8.7, 4.2 Hz, 1H), 
1.79 (brs, 2H), 1.54 – 1.19 (m, 13H), 0.88 (t, J = 6.8 Hz, 3H) ppm; 13C NMR (150 MHz, 
CDCl3):  = 136.2, 117.9, 76.1, 74.2, 32.3, 32.0, 29.8, 29.7, 29.4, 26.0, 22.8, 14.3  ppm; 
HRMS (ESI-QTOF) calcd for C12H24O2
+
 [M
+
]: 200.1776, found: 200.1776. 
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Enone 27: To a deoxygenated solution of tributyl(vinyl)tin (1.58 
g, 5 mmol, 1.0 equiv.), PCy3·HBF4 (368 mg, 1 mmol, 0.2 equiv.), 
i-Pr2NEt (170 μL, 1 mmol, 0.2equiv.), and Pd2(dba)3 (457 mg, 0.5 mmol, 0.1 equiv.) in 
50 mL of toluene was added methyl adipoyl chloride 11 (1.6 mL, 10 mmol, 2.0 equiv.) 
dropwise over 2 minutes and stirred for one hour at room temperature. The reaction 
mixture was diluted with EtOAc (75 mL) organic phase was washed with 3% aq. NH4OH 
(75 mL), water (2 × 75 mL), and brine (75 mL), dried over Na2SO4, and concentrated to 
give a yellow oil. Flash column chromatography (20% EtOAc / hexanes) gave enone 26 
(770 mg, 90.6% yield) as yellow oil. 26: Rf = 0.32 (20% EtOAc / hexanes); IR (thin 
film): max = 2953, 1732, 1699 cm
–1
; 
1
H NMR (600 MHz, CDCl3):  = 6.34 (dd, J = 17.7, 
10.6 Hz, 1H), 6.21 (d, J = 17.6 Hz, 1H), 5.82 (d, J= 10.6 Hz, 1H), 3.66 (s, 3H), 2.61 (m, 
2H), 2.34 (m, 2H) ppm, 1.65 (m, 4H); 
13
C NMR (150 MHz, CDCl3):  = 
13
C NMR (151 
MHz, Chloroform-d) δ 200.5, 174.0, 136.6, 128.2, 51.7, 39.3, 34.0, 24.6, 23.4ppm; 
HRMS (ESI-QTOF) calcd for C9H15O3
+
 [M + H
+
]: 171.1000, found: 171.1017. 
 
Allylic alcohol 28: To enone 26 (50 mg, 0.29 mmol, 1.0 equiv.) 
was added a solution of (R)-Me-CBS (163.35 mg, 0.59 mmol, 2.0 
equiv.) in 300 μL THF and cooled to -78 °C. Then BH3·THF (1 M in THF, 0.3 mL, 0.3 
mmol, 1.0 equiv.) was added dropwise over 1 minute. The reaction was quenched by 
adding 50 μL of methanol and 10 μL of 4 N HCl and warmed to room temperature. The 
reaction mixture was diluted with EtOAc (10 mL). The organic layer was washed with 
water (2 × 10 mL), brine (10 mL), and saturated NaHCO3 (10 mL), dried over Na2SO4, 
and concentrated to give a yellow oil. Flash column chromatography (30% EtOAc / 
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hexanes) gave allylic alcohol 26 as a colorless oil (34 mg, 69.5% yield). 26: Rf = 0.33 
(30% EtOAc / hexanes); []D
23
 = –90.5 ° (c = 1.00, CHCl3); IR (thin film): max = 3433, 
2936, 1735 cm
–1
; 
1
H NMR (600 MHz, CDCl3):  = 5.86 (ddd, J = 17.3. 10.5, 6.2 Hz, 
1H), 5.22 (dd, J = 17.3, 1.0 Hz, 1H ), 5.11 (dd, J = 10.4, 1.0 Hz,1H), 4.10 (m, 1H), 3.66 
(s, 3H), 2.32 (t, J = 7.6 Hz, 2H), 1.71–1.33 (m, 6H)  ppm; 13C NMR (150 MHz, CDCl3): 
 = 174.3, 141.2, 114.9, 73.1, 51.7, 36.7, 34.1, 25.0, 24.9 ppm; HRMS (ESI-QTOF) calcd 
for C9H17O3
+
 [M + H
+
]: 173.1200, found: 173.1172. 
 
Oxylipin 17: Allylic alcohol 28 (85 mg, 
0.49 mmol, 1 equiv) and diol  27 (313 mg, 
1.48 mmol, 3 equiv) were dissolved in 9 mL 
of THF and then Hoyveda Grubbs catalyst (21.1 mg, 0.026 mmol, 0.05 quiv) was added 
and heated to reflux for 24 hours. The reaction mixture was cooled to room temperature 
then LiOH (450 mg, 9.8 mmol, 20 equiv) dissolved in 1 mL water was added and stirred 
for another 24 hours. Reaction mixture was partitioned between EtOAc (20 mL) and 1N 
HCl (20 mL). The organic layer was washed with water (20 mL) and brine (20 mL) and 
dried over Na2SO4 and concentrated to give a white solid. Flash column chromatography 
(90 % EtOAc/hexanes) gave oxylipin 17 (86 mg, 53% yield) as a white solid. 
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CHAPTER 4 
CATALYTIC ENANTIOSELECTIVE ,,-TRIOXYGENATION 
Paper published in full in Organic Letters
*
  
Introduction 
Enantioselective transformations of aldehydes and enals promoted by chiral 
amine catalysts have been heavily studied since 2000.
1
 The most common variants of 
these reactions are aldehyde -functionalizations2 and enal -functionalizations,3 but 
reactions at more-remote sites are also known.
4
 -Oxygenations have been developed 
using nitrosobenzene,
5
 TEMPO radical,
6
 or singlet oxygen
7
 as the oxygen source. -
Oxygenations through conjugate addition of substituted hydroxylamines,
8
 alcohols,
9
 or 
hydrogen peroxide
10
 have been described, but have found limited application due to their 
reversible nature.
11
 A non-enantioselective -oxygenation using TEMPO radical has been 
reported.
12  
 
Organocatalytic cascade reactions
13
 have also been popular. Conjugate addition to 
an ,β-unsaturated iminium ion (generated by condensation of an enal with an amine 
catalyst) forms an enamine whose further reaction with an electrophile leads to ,β-
difunctionalization (1→2, Scheme 1). The  and β positions may form new bonds to the 
same atom, generating a three-membered ring.
14
 More often, the enal is coupled to two 
different reaction partners. Organocatalytic -difunctionalizations involving 
oxygenation at the 15 or 16,9c position have been developed, but organocatalytic - 
dioxygenation is unknown. Some examples of enal -difunctionalization (1→3) have  
*
Reprinted with permission from Org. lett. 2015, 17, 6050. 
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been reported,
17
 but there is no precedent for enal -trifunctionalization 
(organocatalytic or otherwise). However, ipso,-trifunctionalizations of activated 
carboxylic acid derivatives (4→5) have been described.18 
 
 
 
 
 
 
 
 
Scheme 1. Summary of related cascade reactions  
 
We became interested in organocatalytic aldehyde -oxygenation using 
stoichiometric TEMPO
6
 as part of a strategy for preparing anti-1,2-diols from simple 
aldehydes.
19
 The -oxygenation proceeds through an enamine mechanism,6c but the 
optimal catalysts are imidazolidinone salts originally designed to promote enal reactions 
through the intermediacy of ,-unsaturated iminium ions.1b This apparent mismatch led 
us to wonder what would happen if an enal were subjected to the -oxygenation 
conditions. Would -oxygenation proceed with transposition of the alkene? Would 
conjugate addition of a nucleophile occur? Or would -oxygenated be observed? 
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Results and Discussion 
To distinguish these possibilities, we subjected enal 6 (Scheme 2) to the aldehyde 
-oxygenation conditions. Enal 6 and TEMPO reacted under the influence of 
imidazolidinone salt 7·HCl to give -oxyenal 8 and -trioxyaldehyde 9, both in 
racemic form. Using an excess of enal 6 favored formation of -oxyenal 8, and using an 
excess of TEMPO favored trioxyaldehyde 9. Resubjecting -oxyenal 8 to the reaction 
conditions effected its conversion into trioxyaldehyde 9, demonstrating that -oxyenal 8 
likely is an intermediate in the cascade. The relative stereochemistry of trioxyaldehyde 9 
was ascertained by comparing the NMR spectra of tetraacetate derivative 10 against the 
published spectra of all diastereomers of this compound.
20
 Shortly after we commenced 
these experiments, Jang and coworkers reported the conversion of enal 6 into -oxyenal 
(±)-8 under similar reaction conditions;
12
 however, they apparently did not observe 
trioxyaldehyde 9 since they used TEMPO as the limiting reagent. 
 
 
 
 
 
 
 
 
Scheme 2. Discovery of a trioxygenation cascade  
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C5 enal 6 is difficult to observe by TLC analysis due to its moderate volatility, and 
so reaction optimization was conducted on C8 enal 11 (Table 1). Some aldol and Michael 
reaction products were observed, and so enal 11 was added portionwise in order to 
suppress its self-dimerization. The reaction was sluggish, and thus it was run at high 
concentration (500 L of solvent for a 1 mmol reaction) in order to increase the reaction 
rate. At this concentration, TEMPO became a significant contributor to reaction volume; 
to further enhance the initial rate, TEMPO was added in two portions. Under these 
conditions, imidazolidinone salt 7·AcOH delivered trioxyaldehyde 12 in higher yield and 
with superior stereoselectivity as compared with the hydrochloride salt (Table 1, entries 1 
and 2). A solvent screen revealed improved enantioselectivity in toluene, but at the 
expense of yield (Table 1, entries 3–6). Copper(II) chloride was poorly dissolved in 
toluene, and so we speculated that more polar fluorinated aromatic solvents may better 
dissolve the copper salt, and thus rescue the reaction yield while retaining the improved 
stereoselectivity (Table 1, entries 7–10). This proved to be the case; use of 
pentafluorobenzene delivered a higher yield of the major diastereomer than that obtained 
in acetone (albeit with a lower yield of the combined diatereomers) an enantiomeric ratio 
comparable to that achieved in toluene. The anion of the amine salt was then varied, but 
no improvements were forthcoming (Table 1, entries 11 and 12). 
Believing that use of a sterically more demanding catalyst would improve 
enantioselectivity, we switched to tryptophan-derived catalyst 13·AcOH (Figure 1 and 
Table 1, entries 13–15).21 The desired trioxygenation did not proceed in acetone using the 
bulkier catalyst; only aldol and Michael addition products were observed. However, use 
of the bulkier catalyst improved the enantiomeric ratio to 85:15 when the reaction was 
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conducted in pentafluorobenzene. Unfortunately, this change also slowed the conversion 
of the intermediate -oxyenal into trioxyaldehyde 12. The -oxyenal was present in 21% 
yield after 24 hours, but the yield of trioxyaldehyde 12 peaked at this time since the 
product slowly decomposed under the reaction conditions. Nonetheless, a 59% combined 
yield of two diastereomers of 12 was obtained. After aldehyde reduction to facilitate 
chromatographic separation, the major diastereomer was isolated in 51% overall yield 
(i.e., average of 80% yield per oxygenation)  
 
Table 1. Trioxygenation cascade optimization 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a
Combined yield of two major diastereomers, determined by crude NMR in the presence of an internal standard. 
Yields in parentheses refer to the isolated yield of the major diastereomer after NaBH4-mediated 
reduction.Determined by crude NMR. 
c
 Determined by chiral HPLC for the major diastereomer. 
d
 1,3,5-
Trifluorobenzene. ND = not determined. 
entry amine salt solvent yield (%)a drb erc 
1 7·HCl acetone 47 2.7:1 43:57 
2 7·AcOH acetone 78 (57) 4.1:1 61:39 
3 7·AcOH THF 39 9.0:1 66:34 
4 7·AcOH DMSO 0 ND ND 
5 7·AcOH CHCl3 0 ND ND 
6 7·AcOH PhMe 42 5.5:1 73:27 
7 7·AcOH PhCF3 69 (52)
 5.0:1 71:29 
8 7·AcOH C6H3F3
d 54 6.8:1 72:28 
9 7·AcOH C6HF5 66 (59)
 >20:1 70:30 
10 7·AcOH C6F6 48 3.5:1 75:25 
11 7·TFA C6HF5 67 6.2:1 68:32 
12 7·HCl C6HF5 58 5.7:1 71:29 
13 13·AcOH acetone 0 ND ND 
14 13·AcOH PhCF3 45 (36)
 6.4:1 84:16 
15 13·AcOH C6HF5 59 (51)
 8.9:1 85:15 
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Figure 1. Other secondary amine catalysts screened 
Amine salts of ,-diarylprolinols (14) and related silyl ethers (15) also catalyzed 
the formation of trioxyaldehyde 12. However, the reactions became even more sluggish 
when using these catalysts, and neither yield nor stereoselectivity was improved. Proline 
(16), proline methyl ester (17), and their salts did not catalyze the trioxygenation cascade. 
However, proline hydrochloride (16·HCl) proved to be a good catalyst for -oxygenation. 
The 71% isolated yield of -oxyenal 18 (Scheme 3) using enal 11 as the limiting reagent 
is comparable to the best -oxygenation yields reported by Jang and co-workers using 
TEMPO as the limiting reagent.
12 
 
 
 
 
Scheme 3. Proline-catalyzed -oxygenation  
 
As shown in Scheme 4, the optimized reaction of C5 enal 6 gave chiral 
trioxyaldehyde 9, but with a worse enantiomeric ratio than that achieved in the reaction 
of C8 enal 11. The absolute configuration of trioxyaldehyde 9 (and, by extension, the 
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other trioxyaldehydes) was determined by comparing the optical rotation of optically-
active tetraacetate 10 (Scheme 2) against that of the known carbohydrate-derived 
tetraacetate.
22
 Since the functional group tolerance of the reaction condition has already 
been demonstrated in the context of -oxygenation,6 we investigated whether the cascade 
reaction tolerated branching on or near the enal. Substrates with branching at the , , or 
 position did not undergo ,,-trioxygenation or even -oxygenation. Cinnamaldehyde 
was similarly unreactive. -Branching was tolerated (see 19→20), but with poor kinetics. 
Use of the less bulky catalyst 7·AcOH delivered a 38% yield of the combined 
diastereomers, but the enantiomeric ratio suffered. 
 
 
 
 
 
 
 
 
Scheme 4. Trioxygenation of other substrates 
 
We probed the reaction mechanism of the transformation since such knowledge 
might assist design of improved enal ,,-trifunctionalizations. As shown in Scheme 5, 
racemic -oxyenal 18 reacted under the optimized trioxygenation conditions to afford 
trioxyaldehyde 12 in 63% isolated yield (single diastereomer after aldehyde reduction) 
with 82:18 er and racemic recovered starting material ((±)-18) in 25% isolated yield. The 
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64% combined yield of compounds with the (R) configuration at the  position (12% (R)-
18 + 52% major enantiomer of 12) proves that the enantiomers of -oxyenal 18 
interconvert under the reaction conditions to afford dynamic kinetic resolution.
16f,h 
 
 
 
 
 
Scheme 5. Evidence for dynamic kinetic resolution  
 
The above data leads to a clear mechanistic overview of the cascade, outlined in 
Scheme 6 using enal 11 as a model substrate. The reaction proceeds through initial 
formation of -oxyenal 18, a compound that undergoes rapid racemization through the 
intermediacy of dienamine 21. ,-Dioxyaldehyde 22 is not detected, suggesting that 
consistent with the nonaqueous reaction conditions, conjugate addition of water is 
thermodynamically unfavorable.
11
 Our recent computational study on 2,2,6,6-piperidinyl-
masked vicinal diols
23
 reveals a thermodynamic preference for the syn diastereomer of 
22, which adopts a six-membered ring hydrogen bond between the -hydroxyl proton and 
the piperidinyl nitrogen of the masked -hydroxyl group (see 23). The stability conferred 
by this hydrogen bond appears to be critical for achieving a sufficiently-high 
concentration of ,-dioxyaldehyde 22 for the subsequent -oxygenation to proceed at a 
viable rate; recall that cinnamaldehyde is unreactive. Since water addition is reversible 
and the enantiomers of -oxyenal 18 equilibrate, -oxygenation sets all three 
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stereocenters with double dynamic kinetic resolution. The configuration of the masked -
hydroxyl group is consistent with that observed in the -oxygenation of simple 
aldehydes.
6 
 
 
 
 
 
 
 
 
Scheme 6. Proposed trioxygenation mechanism
 
    Conclusion 
In conclusion, we discovered the first enal ,,-trifunctionalization cascade. The 
reported trioxygenation is of limited synthetic utility due to moderate enantioselectivity, 
but the mechanistic insights gained are expected to be useful for the design of improved 
polyfunctionalization cascades. For example, using a tethered nucleophile or a 
nucleophile that adds irreversibly should enhance the overall reaction rate by improving 
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the thermodynamic driving force for the -functionalization step. The latter change might 
also enhance enantioselectivity since the catalyst would be able to exert its influence at 
two steps (- and -functionalization). Efforts to translate these ideas into improved 
cascades are under way. 
 Experimental 
General procedures. 
Unless otherwise noted, all reactions were performed with stirring under an argon 
atmosphere under anhydrous conditions. Reagents were purchased at the most-
economical grade. Dry tetrahydrofuran (THF), N,N-dimethylformamide (DMF), and 
dichloromethane were obtained by passing HPLC grade solvents through commercial 
solvent purification systems. All other chemicals were used as received, without 
purification. Flash column chromatography was performed using Grace Davison Davisil 
silica gel (60 Å, 35–70 m). Unless otherwise noted, yields refer to chromatographically- 
and spectroscopically- (
1
H NMR) homogeneous samples of single diastereomers. Thin-
layer chromatography (TLC) was performed on Grace Davison Davisil silica TLC plates 
using UV light and common stains for visualization. NMR spectra were calibrated using 
residual undeuterated solvent as an internal reference. Apparent couplings were 
determined for multiplets that could be deconvoluted visually. 
 
Primary alcohol 12′. To an uncapped solution of imidazolidinone salt 
13·AcOH (104 mg, 0.30 mmol, 0.30 equiv) in pentafluorobenzene (500 
L) was added AcOH (18 L, 0.30 mmol, 0.30 equiv), CuCl2·2H2O (51 
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mg, 0.30 mmol, 0.30 equiv), and dried powdered 4Å molecular sieves (30 mg). The green 
mixture was stirred for 5 minutes until the copper salt dissolved. The resultant dark 
brown reaction mixture was cooled to 0 °C and kept at this temperature for the remainder 
of the reaction. Addition of octenal 11 (52 L, 0.33 mmol, 0.33 equiv) and TEMPO (315 
mg, 2.00 mmol, 2.00 equiv) resulted in a dark orange color. At 45 and 90 minutes (all 
timings from the initial addition of TEMPO), another equal-sized aliquot of octenal 11 
was added. At 135 minutes, additional TEMPO (473 mg, 3.00 mmol, 3.00 equiv) was 
added. At 24 hours, the reaction mixture was diluted with EtOAc (10 mL) and filtered 
through Celite. The filtrate was partitioned between EtOAc (30 mL) and saturated NH4Cl 
(30 mL). The aqueous phase was extracted with EtOAc (2 × 20 mL), then the combined 
organic layers were washed with brine (50 mL), dried over anhydrous Na2SO4, and 
concentrated to give crude aldehyde 12 as an orange oil. 
To crude aldehyde 12 in ethanol (5 mL) was added NaBH4 (100 mg, excess). The 
reaction mixture was stirred for 10 minutes, then diluted with ether (50 mL) and washed 
with saturated NH4Cl (50 mL), water (50 mL), and brine (30 mL). The organic layer was 
dried over Na2SO4 and concentrated to give an orange oil. Flash column chromatography 
(7% EtOAc / CHCl3) gave a single diastereomer of primary alcohol 12′ (233 mg, 51% 
yield) as a white solid. A sample was derivatized [1. m-nitrobenzoyl chloride, Et3N, 
DMAP (cat.), CH2Cl2; 2. Zn, AcOH, THF, H2O] and determined by chiral HPLC 
[Chiraltech IA column, 2.1 × 100 mm, 3 m; 2% iPrOH / hexanes, 0.2 mL / min; 25 °C; 
280 nM UV detection; Rt = 7.3 (major), 4.9 (minor) minutes] to have 85:15 er. 12′: Rf = 
0.23 (10% EtOAc / hexanes); []D
23
 = −11.1 ° (c = 1.00, CHCl3); IR (thin film): max = 
3320, 2930, 1373 cm
–1
;
 1
H NMR (600 MHz, CDCl3):  = 6.73 (br s, 1H), 5.27 (br s, 1H), 
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4.16 (dd, J = 12.2, 7.8 Hz, 1H), 4.10 – 3.96 (m, 3H), 3.87 (br d, J = 10.8 Hz, 1H), 1.63 – 
1.42 (m, 13H), 1.41 – 1.27 (m, 14H), 1.25 (s, 3H), 1.17 (s, 3H), 1.15 (s, 3H), 1.13 (s, 6H), 
0.91 (t, J = 7.3 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3):  = 81.7, 80.8, 76.6, 64.5, 
61.4, 61.3, 60.5, 60.2, 40.6, 40.5, 40.3, 40.1, 34.41, 34.35, 33.2, 32.3, 30.3, 27.9, 23.1, 
20.74, 20.70, 20.67, 20.64, 17.27, 17.25, 14.3 ppm; HRMS (ESI-QTOF) calcd for 
C26H53N2O4
+
 [M + H
+
]: 457.4005, found: 457.4000. 
 
Primary alcohol 9′. Primary alcohol 9′ was prepared in the same manner 
as primary alcohol 12′, using -trifluorotoluene instead of 
pentafluorobenzene. Flash column chromatography (7% EtOAc / CHCl3) 
gave a single diastereomer of primary alcohol 9′ (44% yield) as a white solid. A sample 
was derivatized [1. m-nitrobenzoyl chloride, Et3N, DMAP (cat.), CH2Cl2; 2. Zn, AcOH, 
THF, H2O] and determined by chiral HPLC [Chiraltech IA column, 2.1 × 100 mm, 3 m; 
2% iPrOH / hexanes, 0.2 mL / min; 25 °C; 280 nM UV detection; Rt = 10.8 (major), 7.3 
(minor) minutes] to have 68:32 er. 9′: Rf = 0.29 (15% EtOAc / hexanes); []D
23
 = +1.9 ° 
(c = 1.00, CHCl3); IR (thin film): max = 3318, 2932, 1373 
cm
–1
;
 1
H NMR (600 MHz, CDCl3):  = 5.94 (br s, 1H), 5.31 (d, J = 8.9 Hz, 1H), 4.21 – 
4.11 (m, 2H), 4.07 (m, 1H), 3.91 – 3.83 (m, 2H), 1.67 – 1.42 (m, 10H), 1.39 – 1.26 (m, 
11H), 1.23 (s, 3H), 1.20 – 1.16 (m, 6H), 1.13 (s, 9H) ppm; 13C NMR (150 MHz, CDCl3): 
 = 81.8, 77.9, 77.5, 77.0, 64.5, 61.4, 60.9, 60.5, 60.2, 40.6, 40.4, 40.3, 40.2, 34.5, 34.4, 
33.1, 32.7, 20.73, 20.70, 20.6, 17.28, 17.27, 16.6 ppm; HRMS (ESI-QTOF) calcd for 
C23H47N2O4
+
 [M + H
+
]: 415.3536, found: 415.3532. 
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Primary alcohol 20′. Primary alcohol 20′ was prepared in the same 
manner as primary alcohol 12′, using imidazolidinone salt 7·AcOH 
instead of imidazolidinone salt 13·AcOH and with a reaction time of 18 
hours instead of 24 hours for the trioxygenation step. Flash column chromatography (7% 
EtOAc / CHCl3) gave a single diastereomer of primary alcohol 20′ (30% yield) as a white 
solid. A sample was derivatized [1. m-nitrobenzoyl chloride, Et3N, DMAP (cat.), CH2Cl2; 
2. Zn, AcOH, THF, H2O] and determined by chiral HPLC [Chiraltech IA column, 2.1 × 
100 mm, 3 m; 2% iPrOH / hexanes, 0.2 mL / min; 25 °C; 280 nM UV detection; Rt = 
9.7 (major), 5.2 (minor) minutes] to have 68:32 er. 20′: Rf = 0.31 (10% EtOAc / 
hexanes); []D
23
 = +16.2 ° (c = 1.00, CHCl3); IR (thin film): max = 3470, 3456, 2926, 
1360 cm
–1
;
 1
H NMR (600 MHz, CDCl3):  = 7.50 (s, 1H), 5.17 (d, J = 8.6 Hz, 1H), 4.30 
(dd, J = 9.2, 3.4 Hz, 1H), 4.21 (dd, J = 12.3, 7.7 Hz, 1H), 4.04 (dt, J = 7.6, 3.1 Hz, 1H), 
3.93 (dd, J = 9.2, 1.9 Hz, 1H), 3.82 (ddd, J = 12.3, 9.0, 3.0 Hz, 1H), 2.01 (doublet of 
septets, J = 6.9, 1.8 Hz, 1H), 1.64 – 1.55 (m, 2H), 1.54 – 1.41 (m, 8H), 1.38 – 1.31 (m, 
8H), 1.290 (s, 3H), 1.286 (s, 3H), 1.19 (s, 3H), 1.16 (s, 3H), 1.15 (s, 6H), 1.12 (d, J = 7.0 
Hz, 3H), 0.99 (d, J = 7.0 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3):  = 84.8, 81.8, 
75.8, 64.1, 62.2, 61.1, 60.8, 60.3, 40.7, 40.6, 40.4, 40.1, 34.7, 34.5, 33.2, 31.8, 29.7, 21.4, 
20.73, 20.69, 20.65, 17.3, 17.2, 15.2 ppm; HRMS (ESI-QTOF) calcd for C25H51N2O4
+
 [M 
+ H
+
]: 443.3849, found: 443.3847. 
 
-Oxyenal 18. -Oxyenal 18 was prepared following the above protocol 
for the synthesis of aldehyde 12, using proline salt 16·HCl instead of 
 82 
imidazolidinone salt 13·AcOH, using DMF instead of pentafluorobenzene, and with a 
reaction time of 18 hours. Flash column chromatography (4% EtOAc / hexanes) gave -
oxyenal 18 (71% yield) as a light yellow oil. A sample was derivatized [1. NaBH, EtOH 
2. m-nitrobenzoyl chloride, Et3N, DMAP (cat.), CH2Cl2; 3. Zn, AcOH, THF, H2O] and 
determined by chiral HPLC [Chiraltech IB column, 2.1 × 100 mm, 3 m; 0.5% iPrOH / 
hexanes, 0.2 mL / min; 25 °C; 280 nM UV detection; Rt = 17.8, 19.1 minutes] to be 
racemic. 18: Rf = 0.40 (5 % Et2O / hexanes); IR (thin film): max = 2931, 1694, 1132 cm
–
1
;
 1
H NMR (600 MHz, CDCl3):  = 9.57 (d, J = 8.0 Hz, 1H), 6.87 (dd, J = 15.9, 8.0 Hz, 
1H), 6.12 (ddd, J = 15.8, 8.0, 0.7 Hz, 1H), 4.43 (dt, J = 5.4, 7.7 Hz, 1H), 1.79 (m, 1H), 
1.58 (m, 1H), 1.50 – 1.23 (m, 10H), 1.18 (s, 3H), 1.14 (s, 3H), 1.09 (s, 3H), 1.06 (s, 3H), 
0.90 (t, J = 7.1 Hz, 3H) ppm; 
13
C NMR (150 MHz, CDCl3):  = 193.7, 159.3, 131.7, 83.1, 
60.1, 59.3, 40.0, 34.5, 33.8, 33.4, 26.9, 22.5, 20.2, 20.1, 16.9, 13.8 ppm; HRMS (ESI-
QTOF) calcd for C17H32NO2
+
 [M + H
+
]: 282.2433, found: 282.2428. 
 
Tetraacetate 10: To a solution of alcohol 9′ (128 mg, 0.31 mmol, 1.0 
equiv.) in 5 mL of 3:1:1 solvent mixture (HOAc:H2O:THF) was added 
zinc (201 mg, 3.1 mmol, 10 equiv.). The reaction mixture was stirred at 70 
°C for one hour. After cooling, the reaction mixture was diluted with dichloromethane 
(20 mL), filtered through Celite, concentrated, and azeotropically dried with toluene to 
give a white solid. To this solid was added pyridine (3.0 mL, excess), Ac2O (3.0 mL, 
excess), and DMAP (1.9 mg, 0.015 mmol, 0.05 equiv.). The reaction mixture was stirred 
for 16 hours, then partitioned with EtOAc (30 mL) and 0.5 N HCl (30 mL). The organic 
phase was washed with water (2 × 30 mL) and brine (20 mL), dried over Na2SO4, and 
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concentrated to give a white solid. Flash column chromatography (20% EtOAc / hexanes) 
gave tetraacetate 10 (41 mg, 43% yield) as a white solid. 10: Rf = 0.31 (30% EtOAc / 
hexanes); []D
23
 = +11.6 ° (c = 1.00, CHCl3); IR (thin film): max = 2927, 1738, 1373, 
1212 cm
–1
;
 1
H NMR (600 MHz, CDCl3):  = 5.23 (dd, J = 8.4, 3.0 Hz, 1H), 5.20 – 5.15 
(m, 2H), 4.24 (dd, J = 12.4, 2.5 Hz, 1H), 4.15 (dd, J = 12.5, 5.0 Hz, 1H), 2.14 (s, 3H), 
2.053 (s, 3H), 2.050 (s, 3H), 2.04 (s, 3H), 1.18 (d, J = 6.5 Hz, 3H) ppm; 
13
C NMR (150 
MHz, CDCl3):  = 170.8, 170.4, 170.1, 170.0, 71.6, 68.7, 67.5, 62.1, 21.1, 20.9, 20.84, 
20.77, 16.4 ppm; HRMS (ESI-QTOF) calcd for C13H21O8
+
 [M + H
+
]: 305.1236, found: 
305.1237. 
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CHAPTER 5 
CONCLUSION 
The new methodology to access differentially protected anti-1,2-diols from 
organomagnesium or organolithium addition to -oxyaldehydes is described in the 
second chapter. Anti-1,2-diols can be synthesized with high diastereoselectivity applying 
the method developed, regardless of the hybridization or the nature of branching of the 
incoming carbon nucleophile.  However, the attempts to optimize of the protocol towards 
complete syn selectivity, using chelating metal salts was not successful suggesting that 
the TMP masking group on the -hydroxyl group is too bulky to be coordinated. 
However, initial diastereoselectivity was often degraded when the chelating agents were 
introduced. As a solution, oxidation of anti-1,2-diols followed by reduction of the 
corresponding ketones was used to deliver masked syn-1,2-diols. 
The third chapter showcases the application of the 1,2-diol synthesis discussed in 
chapter two in a short synthesis of unnamed oxylipins isolated from the Peruvian plant 
Dracontium loretense. In the first generation, we synthesized all possible diastereomers 
of oxylipins and compared the NMR spectroscopic data and polarimetry data of the 
synthetic oxylipins with what was reported by isolation chemists, which led to the 
unambiguous absolute stereochemical determination of natural oxylipins isolated from 
Dracontium loretense. Furthermore, the absolute configuration of the natural 
immunostimulant is 6R, 9S, 10R, whereas the natural oxylipin with syn 1,2-diol moiety is 
6R, 9S, 10S. Our seven step long first generation synthesis is tied for the shortest 
synthesis of oxylipins containing the 3-ene-1,2,5-triol moiety. However, our synthesis is 
the shortest route to access oxylipins with anti-1,2-diol moiety. Furthermore, 
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incorporation of olefin metathesis and minimalizing masking group transformations in 
our second generation synthesis led to development of shortest ever oxylipin synthesis 
with three steps. This synthesis is not only the shortest, but also it is the most efficient 
synthesis with highest overall yield (33%). Also, optimization of the organocatalytic 
enantioselective -oxygenation via oxidative incorporation of TEMPO to explore low 
organocatalyst loadings is one of the outcome of the our second generation oxylipin 
synthesis. Furthermore, our 5 mol % loading of chiral imdazolidinone salts is the lowest 
ever reported catalyst loading for any reported organocatalytic, enantioselective -
oxygenation of aldehydes via oxidative incorporation of TEMPO. 
Subjecting an enal to the enantioselective organocatalytic enantioselective -
oxygenation, led to the discovery of the first ever ,,-trifunctionalization cascade of 
enals, which is detailed in chapter 4. Moderate yields and enantioselectivities were 
observed in trioxygenation when tryptophan based chiral imidazolidinones were used as 
the catalyst in fluorinated aromatic solvents. Moreover, the trioxygenation reaction 
cascade proceeds via initial -incorporation of TEMPO to the enal, which undergoes 
rapid racemization. Next, the reversible conjugate addition of water followed by final -
incorporation of TEMPO sets all three chiral centers with double dynamic kinetic 
resolution. 
Future work in this ,,-trifunctionalization cascade of enals includes further 
optimization of enantioselectivity. However, one of the problems of optimization of the 
enantioselectivity of the ,,-trioxygenation is the reversible conjugate addition of water 
to enal. Therefore, incorporation of a tethered oxygen nucleophile such as a hydroxyl 
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group, which can make a thermodynamically favorable ring at  position, could 
overcome the thermodynamically unfavorable nature of the conjugate addition of oxygen 
nucleophile (Scheme 1). Hence, enantioselectivity may be improved. Moreover, use of 
different nucleophiles such as the anion of diethyl malonate, nitrile could introduce 
different functionalities at the  position of the enal. 
 
 
 
 
 
Scheme 1: Cyclic ether synthesis 
 
Another potential direction is the extension of this ,,-trioxygenation 
technology to polyoxygenation of extended enals 4. The resultant masked 
polyoxygenated aldehyde may deliver a protected hexose 6 upon cyclization (Scheme 2).  
 
 
Scheme 2: Extended polyoxygenation towards hexoses synthesis. 
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APPENDIX A 
CHAPTER 1: ANTI 1,2-DIOLS FROM α-OXYALDEHYDES 
NMR SPECTRA 
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1
H NMR spectrum (600 MHz, CDCl3) of aldehyde 10: 
 
13
C NMR spectrum (150 MHz, CDCl3) of aldehyde 10: 
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1
H NMR spectrum (600 MHz, CDCl3) of alcohol 11: 
 
13
C NMR spectrum (150 MHz, CDCl3) of alcohol 11: 
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1
H NMR spectrum (600 MHz, CDCl3) of alcohol 13: 
 
13
C NMR spectrum (150 MHz, CDCl3) of alcohol 13: 
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1
H NMR spectrum (600 MHz, CDCl3) of alcohol 14 
 
 
13
C NMR spectrum (150 MHz, CDCl3) of alcohol 14: 
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1
H NMR spectrum (600 MHz, CDCl3) of alcohol 15: 
 
13
C NMR spectrum (150 MHz, CDCl3) of alcohol 15: 
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1
H NMR spectrum (600 MHz, CDCl3) of alcohol 16: 
 
13
C NMR spectrum (150 MHz, CDCl3) of alcohol 16: 
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1
H NMR spectrum (600 MHz, CDCl3) of alcohol 17: 
 
13
C NMR spectrum (150 MHz, CDCl3) of alcohol 17: 
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1
H NMR spectrum (600 MHz, CDCl3) of alcohol 18: 
13
C NMR spectrum (150 MHz, CDCl3) of of alcohol 18: 
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1
H NMR spectrum (600 MHz, CDCl3) of alcohol 19: 
13
C NMR spectrum (150 MHz, CDCl3) of alcohol 19: 
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1
H NMR spectrum (600 MHz, CDCl3) of ketone 20: 
13
C NMR spectrum (150 MHz, CDCl3) of ketone 20: 
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1
H NMR spectrum (600 MHz, CDCl3) of alcohol 21: 
13
C NMR spectrum (150 MHz, CDCl3) of alcohol 21: 
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APPENDIX B 
Chapter 2: TOTAL SYNTHESIS OF OXYLIPINS ISOLATED FROM  Dracontium 
loretense 
NMR SPECTRA 
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1
H NMR spectrum (600 MHz, CDCl3) of -oxyaldehyde 4: 
 
13
C NMR spectrum (150 MHz, CDCl3) of -oxyaldehyde 4: 
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1
H NMR spectrum (600 MHz, CDCl3) of vinylstannane 9: 
 
 
13
C NMR spectrum (150 MHz, CDCl3) of vinylstannane 9: 
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1
H NMR spectrum (600 MHz, CDCl3) of enone 13: 
 
13
C NMR spectrum (150 MHz, CDCl3) of enone 13: 
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1
H NMR spectrum (600 MHz, CDCl3) of allylic alcohol 14: 
 
13
C NMR spectrum (150 MHz, CDCl3) of allylic alcohol 14: 
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1
H NMR spectrum (600 MHz, CDCl3) of silyl ether 10: 
 
13
C NMR spectrum (150 MHz, CDCl3) of silyl ether 10: 
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1
H NMR spectrum (600 MHz, CDCl3) of enone 12: 
 
13
C NMR spectrum (150 MHz, CDCl3) of enone 12: 
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1
H NMR spectrum (600 MHz, CDCl3) of enone 15: 
 
 
13
C NMR spectrum (150 MHz, CDCl3) of enone 15: 
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1
H NMR spectrum (600 MHz, CDCl3) of alcohol 20: 
 
13
C NMR spectrum (150 MHz, CDCl3) of alcohol 20: 
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1
H NMR spectrum (600 MHz, CDCl3) of allylic alcohol 21: 
 
13
C NMR spectrum (150 MHz, CDCl3) of allylic alcohol 21: 
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1
H NMR spectrum (600 MHz, CDCl3) of allylic alcohol 23: 
 
13
C NMR spectrum (150 MHz, CDCl3) of allylic alcohol 23: 
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1
H NMR spectrum (600 MHz, CD3OD) of triol 16: 
 
13
C NMR spectrum (150 MHz, CD3OD) of triol 16: 
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1
H NMR spectrum (600 MHz, CD3OD) of triol 18: 
 
13
C NMR spectrum (150 MHz, CD3OD) of triol 18: 
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1
H NMR spectrum (600 MHz, CD3OD) of triol 21’: 
 
13
C NMR spectrum (150 MHz, CD3OD) of triol 21’: 
 
 116 
1
H NMR spectrum (600 MHz, CD3OD) of triol 23’: 
 
13
C NMR spectrum (150 MHz, CD3OD) of triol 23’: 
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1
H NMR spectrum (600 MHz, CD3OD) of oxylipin (6S,9R,10S)-17: 
13
C NMR spectrum (150 MHz, CD3OD) of oxylipin (6S,9R,10S)-17: 
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1
H NMR spectrum (600 MHz, CD3OD) of oxylipin (6R,9R,10S)-19: 
13
C NMR spectrum (150 MHz, CD3OD) of oxylipin (6R,9R,10S)-19:
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1
H NMR spectrum (600 MHz, CD3OD) of oxylipin (6S,9S,10S)-22: 
 
13
C NMR spectrum (150 MHz, CD3OD) of oxylipin (6S,9S,10S)-22: 
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1
H NMR spectrum (600 MHz, CD3OD) of oxylipin (6R,9S,10S)-24: 
 
13
C NMR spectrum (150 MHz, CD3OD) of oxylipin (6R,9S,10S)-24: 
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1
H NMR spectrum (600 MHz, CDCl3) of diol 26: 
 
13
C NMR spectrum (150 MHz, CDCl3) of diol 26: 
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1
H NMR spectrum (600 MHz, CDCl3) of enone 27: 
13
C NMR spectrum (150 MHz, CDCl3) of enone 27: 
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1
H NMR spectrum (600 MHz, CDCl3) of allylic alcohol 28: 
 
13
C NMR spectrum (150 MHz, CDCl3) of allylic alcohol 28: 
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APPENDIX C 
CHAPTER 3 : CATATYLTIC ENANTIOSELECTIVE 
α,β,- TRIOXYGENATION 
NMR SPECTRA AND HPLC TRACES 
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1
H NMR spectrum (600 MHz, CDCl3) of primary alcohol 9′: 
 
13
C NMR spectrum (150 MHz, CDCl3) of primary alcohol 9′: 
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HPLC trace of a derivative of primary alcohol 9′: 
 
 
 
 
Chiraltech IA column, 2.1 × 100 mm, 3 m 
2% iPrOH / hexanes, 0.2 mL / min, 25 °C 
280 mm UV detection 
 
 
retention time / min absolute area relative area (%) 
  7.3 230573 32.31 
10.8 482961 67.69 
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1
H NMR spectrum (600 MHz, CDCl3) of tetraacetate 10: 
 
13
C NMR spectrum (150 MHz, CDCl3) of tetraacetate 10:  
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1
H NMR spectrum (600 MHz, CDCl3) of primary alcohol 12′: 
 
13
C NMR spectrum (150 MHz, CDCl3) of primary alcohol 12′: 
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HPLC trace of a derivative of primary alcohol 12′: 
 
 
 
 
Chiraltech IA column, 2.1 × 100 mm, 3 m 
2% iPrOH / hexanes, 0.2 mL / min, 25 °C 
280 mm UV detection 
 
 
retention time / min absolute area relative area (%) 
4.9   83302 14.72 
7.3 482529 85.28 
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1
H NMR spectrum (600 MHz, CDCl3) of -oxyenal 18: 
 
13
C NMR spectrum (150 MHz, CDCl3) of -oxyenal 18: 
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1
H NMR spectrum (600 MHz, CDCl3) of primary alcohol 20′: 
 
13
C NMR spectrum (150 MHz, CDCl3) of primary alcohol 20′:  
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HPLC trace of a derivative of primary alcohol 20′: 
 
 
Chiraltech IA column, 2.1 × 100 mm, 3 m 
2% iPrOH / hexanes, 0.2 mL / min, 25 °C 
280 mm UV detection 
 
retention time / min absolute area relative area (%) 
5.2 280247 32.18 
9.7 590595 67.82 
 
 
